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GIT1, 1PIX and PAK are components of a functional protein complex that 
associated with focal adhesion complexes (FCs) via paxillin . This protein complex 
was particularly enriched at the FCs generated by Cdc42 and Rac1, and PAK was 
active at these sites. Detailed analysis of GIT1 revealed the role of the leucine zipper 
domain in mediating protein oligomerisation and was potentially auto-inhibited by a 
putative  helical region at the carboxyl terminus. This GIT1 oligomerisation 
increased 1PIX interaction that was necessary for its efficient recruitment to FCs. The 
localisation of GIT1 and 1PIX at these sites appeared to be negatively regulated by 
the activity of PAK. I have established that such a mechanism involved GIT1 
phosphorylation at serine 517 and might lead to decreased oligomerisation. The GIT1-
1PIX interaction also partitioned both proteins as well as PAK to a detergent-
insoluble cellular fraction, which was potentially regulated by GIT1 Arf GAP domain.  
 
GIT1-paxillin  interaction was repressed by amino terminally located GIT1 ankyrin 
repeats probably involving intra-molecular interaction between the ankyrin repeats and 
the carboxyl terminal located paxillin  binding domain. This domain contained a 
putative alpha helical region, which upon disruption abolished paxillin  binding. 
Furthermore, this helix also exhibited intrinsic auto-inhibition over GIT1 
oligomerisation. Both PAK and 1PIX were shown to interact with paxillin  only 
indirectly through GIT1. Surprisingly this GIT1 protein complex could be recruited to 
FCs independently of paxillin  binding.  A novel interaction between GIT1 and the 
cAMP dependent kinase PKA was found in which PKA phosphorylated GIT1 at serine 
419, adjacent to the leucine zipper domain. Evidence was presented that this PKA 
  VII  
phosphorylation negatively regulated GIT1 and paxillin  interaction perhaps by 
interfering with oligomerisation. 
 
GIT1 was shown to drive PAK auto-phosphorylation and kinase activation in co-
operation with 1PIX. This GIT1 function was dependent on the structural integrity of 
the Arf GAP domain but was neither dependent on Arf GAP activity per se nor 
interaction with paxillin. Active Arf6 partially blocked this function of GIT1 perhaps 
by occluding the domain through physical binding. This GIT1-mediated activation of 
PAK was independent of Cdc42 and Rac1 binding, and occurred both with PAK and 
PAK isoforms. Thus it was anticipated in the cellular context, GIT1 and PIX 
provided both localisation and activation cues for PAK at the FCs. The existence of the 
GIT1/PIX/PAK protein complex allowed integration of signalling inputs through GIT1 
to PAK activation in Rho GTPases signalling pathways. 
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Chapter 1  Introduction 
 
I Regulation of Rho p21s and effectors in actin cytoskeleton /focal adhesion 
complex formation 
 
Rho p21s and regulatory proteins 
Rho p21s are small GTP binding proteins and possess slow intrinsic GTPase activity. 
These p21s are active when GTP bound and signal to downstream effectors; this 
signalling is switched off when the bound GTP hydrolyses to GDP. These p21s are 
positively regulated by guanine nucleotide exchange factors (GEFs) that stimulate GTP 
loading (Hoffman and Cerione, 2002), negatively regulated by GTPase activating 
proteins (GAPs) that accelerate GTPase activity (Peck et al., 2002) and guanine 
nucleotide dissociation inhibitors (GDIs) that bind GDP-bound p21 and blocks GEF 
action (Hart et al., 1992).  
         
 




Effectors leading to  
actin cytoskeleton 
& focal adhesion complex  
rearrangements 
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Rho p21s induce actin cytoskeletion and focal adhesion complex rearrangements 
Rho p21s are implicated in cytokines-, growth factors- as well as integrin signalling 
pathways (Clark et al., 1998). The most well characterised members,  like RhoA, Rac1 
and Cdc42 are involved with actin cytoskeleton rearrangement. RhoA regulates the 
assembly of actin stress fibres that traverse the cytoplasm (Ridley and Hall 1992). Rac1 
organises actin meshwork in lamellipodium formation (Ridley et al., 1992). Cdc42 
triggers thin bundles of actin filaments in filopodium formation at the cell periphery 
(Nobes and Hall, 1995, Kozma et al., 1995, Hall and Nobes, 2000). Besides the actin 
cytoskeleton, these Rho p21s also regulate the formation of cell-extracellular matrix 
(ECM) attachment sites known as focal adhesion complexes (FCs) that are connected 
with respective actin structures (Nobes and Hall, 1995). Rho p21s driven FCs are 
morphologically distinct (Geiger and Yamada, 2001). RhoA- type FCs are elongated 
structures near the cell periphery, their formation is dependent on actomyosin 
contractility and provides strong adhesion to ECM. Cdc42- and Rac1-types FCs are 
smaller dot-like structures at edges of filopodia and lamellipodia respectively. These 
FCs can mature into RhoA-type structures and they share many common molecules. 
Cdc42- and Rac1 dependent structures are dynamic and associate at the extending front 
of the migrating cell. RhoA dependent structures are necessary for cell body traction, 
and these structures have to be disassembled at the cell rear for cell movement (Ridley, 
2001). 
 
These FCs are more than merely attachment sites but also modulate signalling 
pathways (Schwartz and Ginsberg, 2002); FCs are the cellular platform for dynamic 
protein assemblies along the ventral plasma membranes of adherent cultured cells. The 
transmembrane integrin receptors consisting of  and  sub-units are the molecular 
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linkage between the ECM and the intracellular actin cytoskeleton. In the cytoplasmic 
face of FCs, protein assemblies consisting of cytoskeletal proteins, tyrosine- and 
serine/threonine kinases, regulators of GTPases, tyrosine phosphatases and other 
enzymes are found (Zamir and Geiger, 2001). 
 
Paxillin  is an example of protein found at the FCs and it is characterised by multiple 
protein-protein interaction modules (Turner, 2000a & b, Schaller, 2001) as illustrated 
in (Figure 1.1, page 4). These short LD motifs mediate interactions with molecules 
like vinculin, focal adhesion kinase (FAK), actopaxin, and PKL (GIT2 homologue) 
(Turner et al., 1999) or GIT1 (Zhao et al., 2000b). Vinculin and actopaxin have actin 
binding function. GIT1 and its protein partners, PIX (a Rac1 GEF) and PAK (ser/thr 
kinase) are the research topic in this thesis; GIT1 and PIX functions are studied with 
respect to their role in recruiting PAK to FCs and kinase activation. The FCs are major 
sites of tyrosine phosphorylation events downstream of FAK and Src kinase (Schaller 
and Parsons, 1999). FAK activity has been implicated in the disassembly of FCs 
necessary for cell movement (Ilic et al., 1995, Parsons et al., 2000) through the down-
regulation of Rho activity (Ren et al., 1999 & 2000). FAK/Src phosphorylation of 
paxillin  at tyrosine 31 and 118 provides docking sites for Crk adaptor (and p130Cas). 
Src kinase binds to a proline-rich region at the amino terminus of paxillin , and 
phosphorylates p130Cas to drive cell motility. Negative regulators like Csk and PTP-
PEST also bind to paxillin  to inhibit Src and de-phosphorylate p130Cas respectively. 
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LD4 Motif   Binding Partners 
    (direct)   (indirect) 
 
LD1  MDDLDALLADLES    actopaxin, vinculin                 actin (via actopaxin & 
vinculin) 
LD2  LSELDRLLLELNA      vinculin, FAK                            
 
LD3  ESLLDELESSVPS       none 
 
LD4  TRELDELMASLSD     FAK, PKL (GIT1)                   PIX, PAK (via PKL) 
 





Figure 1.1: Paxillin and protein-protein interaction modules. Paxillin  is an 
adaptor protein that binds multiple proteins through its LD motifs; the LD4 motif 
mediates direct binding to FAK and GIT1 and indirect binding to PIX and PAK via 
GIT1. Tyrosine phosphorylation of paxillin  at Y31 and Y118 residues by FAK, 
allows binding of Crk and p130Cas. A proline rich (PR) motif at the amino terminus of 
paxillin  binds Src kinase while LIM3 and LIM4 domains mediate binding to PTP-
PEST. Paxillin is localised to FCs by its LIM3 binding to the integrin receptor’s 
tail. 
LD1 LD2 LD3 LD4 LD5 LIM1 LIM2 LIM3 LIM4
Crk/ p130Cas 
Y31   Y118                                                     PTP-PEST
PR motif                                               Focal adhesion 
for Src binding                                       localisation 
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RhoA effectors and actin stress fibre formation 
Upon GTP binding, Rho p21s switch regions undergo conformational change (Vetter 
and Wittinghofer, 2001) for binding and activation of effectors (Figure 1.2, page 8). 
RhoA effectors for actin stress fibre formation include ROK kinase (or ROCK) and 
mDia (Leung et al., 1996, Amano et al., 1997, Watanabe et al, 1999, Nakano et al., 
1999). mDia induces actin polymerisation through its binding to profilin-actin 
monomer (Watanabe et al, 1997). ROK regulates actomyosin contractility by 
inhibiting myosin phosphatase thereby maintaining myosin light chain (MLC) 
phosphorylation by MLCK (Kimura et al., 1996, Kawano et al., 1999) or direct MLC 
phosphorylation (Totsukawa et al., 2000). MLC phosphorylation is necessary for 
myosin II ATPase activity; the association of myosin II with filamentous actin (F-actin) 
leads to contractile actin stress fibre formation. RhoA also increases PI (4.5) P2 levels 
through PI (4) P5 kinase (Chong et al., 1994, Ren et al., 1998). PI (4.5) P2 regulates 
ERM proteins for the attachment of actin stress fibres to plasma membrane (Sechi and 
Wehland, 2000). RhoA-type FCs are strictly dependent on actomyosin contractility of 
actin stress fibres (Chrzanowska-Wodnicka and Burridge, 1996) which distinguishes it 
from others FCs. 
 
Cdc42 and Rac1 effectors in filopodium and lamellipodium formation  
Cdc42 and Rac1 effectors include WASP, WAVE (downstream of IRS53) which 
regulate Arp2/3 to drive branched actin polymerisation (Takenawa and Miki, 2001). 
For WASP, Cdc42 and PIP2 binding will activate the WASP protein to recruit Arp2/3 
for actin polymerisation. MRCK is another Cdc42 effector implicated in filopodium 
formation (Leung et al., 1998), and its mechanism of action includes phosphorylation 
of MLC since its kinase domain is related to ROK kinase. The role of this MLC 
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phosphorylation in the Cdc42 context is unclear, since filopodia are not known to 
contain myosin II. 
 
Another well characterised effector is p21-activated kinase (PAK) which is activated 
upon Cdc42 or Rac1 binding (Manser et al., 1994). Under certain conditions PAK 
localised to RhoA-, Cdc42- and Rac1-type FCs (Manser et al., 1997). In line with the 
localisation of mammalian PAK, the Drosophila Dpak homologue is enriched at the 
FCs of epithelial cells during embryonic dorsal closure (Harden et al., 1996). 
Constitutively active PAK mutants generated to assess the role of the kinase on the 
actin cytoskeleton showed that PAK caused loss of RhoA-type actin stress fibres and 
FCs with concomitant cell collapse (Manser et al., 1997, Frost et al., 1998). This is 
consistent with PAK kinase acting downstream of Cdc42, mediating the antagonism 
between Cdc42 and RhoA (Kozma et al., 1995 & 1997, Lim et al., 1996). Conversely, 
PAK kinase inhibition prevented the loss of stress fibre normally induced by active 
Cdc42 (Zhao et al., 1998). PAK activity can directly inhibit MLCK whose activity is 
required for the maintenance of myosin II in actin stress fibres (Sanders et al., 1999). 
However the ability of PAK1 to drive lamellipodium formation is independent of its 
p21-binding and kinase activities (Sells et al., 1997, Daniels et al., 1998). PAK 
interaction with its protein partner PIX (a weak Rac1 GEF) might be accountable for 
these morphological effects (Manser et al., 1998, Bagrodia et al., 1998, Obermeier et 
al., 1998); PAK-PIX interaction also positively modulates PIX’s exchange activity 
resulting in Rac1 activation (Daniels et al., 1999). PAK has been implicated in cell 
migration (Sells et al., 1999, Kiosses et al., 1999). 
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The Cdc42 and Rac1 ‘effector loop’ mutants have been employed in deciphering the 
involvement of downstream effectors. However in these studies, a role for PAK in 
actin cytoskeleton reorganisation was brought into question. It has been noted by 
several laboratories that the Rac1 Y40H or Y40C mutations, which cannot bind to 
PAK, are capable of inducing lamellipodium formation and ruffling (Lamarche et al., 
1996, Westwick et al., 1997).    








Figure 1.2: Rho effectors (boxed) and their role in actin structures formation. 
Actin polymerisation is mediated by respective effectors; mDia in Rho signalling, 
WAVE in Rac signalling and WASP in Cdc42 signalling. ROCK through inhibition of 
the myosin phosphatase, maintains the myosin light chain phosphorylation (by MLCK) 
necessary for contractile F-actin (stress fibres) formation. PAK phosphorylates and 
activates LIM kinase, which in turn phosphorylates and inhibits cofilin activity 
resulting in stabilisation of F-actin. PAK also phosphorylates and inhibits myosin light 
chain kinase (MLCK), resulting in reduced actomyosin contractility and stress fibre 
formation. 
Rho Rac Cdc42
                                                                 MLCK                                   WAVE
Profilin mysoin phosphatase (P) LIM kinase (P)                              Arp2/3
                       myosin light chain (P) cofilin (P)
actin   actomyosin  inhibition of actin   actin
polymerisation    contractility                  depolymerisation   polymerisation
stress fibres   lamellipodia filopodia
mDia ROCK PAK IRS53 WASP
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II Mechanism of PAK activation  
 
Structural features of PAK 
PAK is a prototype Cdc42 and Rac1 effector first identified in p21 overlay assays 
(Manser et al., 1994). Mammalian PAKs include three isoforms PAK1), PAK3) 
and PAKManser et al., 1995, Teo et al., 1995, Bagrodia et al., 1995); overall 
sequence homology between  and PAK is 79%. PAK is a serine/threonine kinase 
whose kinase domain shares sequence identity with yeast Ste20p and PAK-like 
proteins in other organisms (Figure 1.3, page 10). PAK regulatory domain contains the 
GTPase (or p21)-binding and a number of proline-rich motifs (Figure 1.4, page 10). 
The conserved residues (ISxPx4-6HxxH) for GTPase binding is dubbed the Cdc42 and 
Rac interactive binding (CRIB) motif  (Burbelo et al., 1995) and is commonly found in 
a variety of effectors (Pirone et al., 2001). Point mutations in the CRIB motif of PAK 
resulted in a loss of GTPase binding and consequent kinase activation (Zhao et al., 
1998). Intriguingly, mutations in the carboxyl terminus to this CRIB motif resulted in 
GTPase-independent kinase activation suggesting that this region is inhibitory. Indeed, 
a PAK fragment (residue 83-149) was found to block PAK activation by Cdc42 and 
was termed the kinase inhibitory domain (KID). This domain is conserved among 
PAKs (Manser and Lim, 1999) and exhibited similar inhibitory effects in yeast PAK1 
and Ste20p (Tu and Wigler, 1999, Lamson et al., 2002). Three proline-rich (PR) motifs 
are dispersed in the regulatory domain; the first and second PR mediate binding to 
adaptor proteins Nck (Galisteo et al., 1996, Bokoch et al., 1996) and Grb2 respectively 
(Puto et al., 2003) and the third PR binds to PIX (Manser et al., 1998). Atypical PAK 
members have recently emerged (Jaffer and Chernoff, 2002) which do not contain the 
KID and PIX-binding PR motif, and their kinase activities are apparently not regulated 
by binding to Cdc42 or Rac1.  
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Figure 1.3: PAK family members. This schematic drawing is reproduced from Lim et 
al., 1996. The sequence identities (%) of the p21-binding and kinase domains are 
relative to rat PAK.PAK and PAK are of rat origin, Drosophila PAK (DPAK), C. 






Figure 1.4: Schematic domains of rat PAK. The amino terminus contains three 
proline rich sequences (PR1-3); they mediate binding to Nck, Grb2 and PIX 
respectively. Mutations in the CRIB motif (denoted by #) abolished Cdc42 or Rac1 
binding and kinase activation. Mutations in the region immediately after the CRIB (**) 









P21 binding kinase domain
94.7%                                                   96%
94.7%                                      92.7%
78.9%                                                               82.5%
71.9%                                                      76%
52.6%                                                           68.1%
61.4%                                                  62.5%
49.1%                                                                   58%
PR1  PR2                                 PR3
Nck  Grb2                                PIX
CRIB
71              131
## **
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Crystal structural of PAK1 
The crystal structure was solved using two fragments of PAK1 consisting of the 
regulatory (residue 70-149)- and kinase (residue 249-545) domains, which provided 
information about the supposedly inhibitory function (Lei et al., 2000). From this 
crystal structure (Figure 1.5, page 12), three features are noted; PAK1 dimerisation 
(Di), an inhibitory switch (IS) region that contacts both the p21 and the large lobe of 
the kinase domain, and the kinase inhibitor (KI) is the carboxyl terminal extension of 
IS. The residues of the IS domain form hydrophobic interactions with the large lobe of 
the kinase domain and thereby positions the KI segment across the cleft of the kinase 
domain. The K141 in the KI segment makes contact with D389 and D407 residues and 
perturbs ATP binding.  
 
PAK kinase-activating mutations correspond to this IS domain (Zhao et al., 1998, Tu 
and Wigler, 1999) and supposedly interfere with the IS-kinase interface. Subsequently 
it was reported that kinase inhibition by the IS/KI occurs in trans in PAK1 dimer, and 
that the dimer did not facilitate PAK trans-phosphorylation. Cdc42 binding would 
disrupt PAK dimerisation resulting in kinase activation (Parrini et al., 2002). However, 
phosphorylation of PAK1 was necessary for Cdc42 binding (ie convert it from a low 
affinity to high affinity Cdc42 binder), for subsequent full kinase activation (Buchwald 













Figure 1.5: Ribbon diagram of dimeric PAK1. This figure is reproduced from Lei et 
al, 2000. PAK1 structure is dimeric; chains A and C are discontinuous in one molecule 
and represented by different colours, chains B and D are in green in the other molecule. 
Chains A and B are the regulatory regions, chains C and D are the kinase domains 
consisting of large and small lobes. Secondary structures ( strands and  helices) in 
chain A and part of the large kinase lobe are labelled. The I	 strand forms the dimer 
interface. The IS domain consists of I2 hairpin and three  helices (I1-3); helices 
I2 and I3 form a hydrophobic interface (reinforced by peripheral polar contacts) 
with the large lobe of kinase domain (helices EF and G). The KI is a C-terminal 
extension of the IS domain, and it interacts with the activation loop and stabilises the 
inhibitory conformation. The dotted line in chain C represents the disordered activation 
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PAK auto-phosphorylation and kinase activation  
Upon Cdc42.GTP or Rac1.GTP binding, mammalian PAKs undergo auto-
phosphorylation and kinase activation (Manser et al., 1997, Gatti et al., 1999, Chong et 
al., 2001). The ,  and PAK auto-phosphorylation sites are largely conserved; there 
are six serine sites in the regulatory domains (S21, S57, S144, S149, S198 and S203 
with S149 being unique to PAK). The threonine site (T422) at activation loop appears 
to be the only auto-phosphorylation site in the kinase domain. Both auto-
phosphorylation  at S144 and T422 in PAK, and at equivalent sites in PAK and 
PAK contributed to kinase activation. These auto-phosphorylation might relieve the 
inhibitory function of the IS/KI (Chong et al., 2001, Zenke et al., 1999). Auto-
phosphorylation of S21 and S198/203 (near the first and third PR motifs which mediate 
Nck- and PIX binding) of PAK are suggested to down-regulate these protein 
interactions (Zhao et al., 2000a). 
 
GTPase (p21)-independent PAK activation  
PAK2 kinase can be activated by caspase cleavage between the regulatory and kinase 
domains during apoptosis (Rudel and Bokoch, 1997). Auto-phosphorylation at T402 is 
necessary for kinase activation following cleavage (Walter et al., 1998). Caspase 
induced kinase activation is unique to PAK2 since other isoforms do not contain this 
caspase recognition site. PAK and P
are activated by sphingosine and the auto-
phosphorylation profiles are identical to that activated with Cdc42.GTP (Chong et al., 
2001, Roig et al., 2001, Bokoch et al., 1998). Sphingosine appears to act at a different 
site from Cdc42 (Chong et al., 2001).  
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III PIX family of GEF and PAK activation 
 
PIX, 1PIX and splice variants 
Two PIX isoforms,  and  (later designated as 1), bind to PAK through their SH3 
domain (Manser et al., 1998). Three alternatively spliced forms of 1PIX (1PIX–b, 
1PIX–c and 2PIX) are thought to correspond to the multiple protein bands in tissue 
extracts in Western blot analysis with an anti-PIX SH3 antibody (Koh et al., 2001). 
The domain organisation of these PIX members is illustrated in (Figure 1.6, page 16); 
they share common SH3, tandem DH and PH domains that are signature features of the 
Rho GEF family (Hoffman and Cerione, 2002). 1PIX has been reported to exhibit 
weak in vivo exchange activity towards Rac1 but not Cdc42 (Manser et al., 1998).  
 
Expression of PIX or 1PIX but not the 2PIX isoform produced membrane ruffles 
in HeLa cells and was dependent on the coiled coil domain (Manser et al., 1998, Koh 
et al., 2001). This coiled coil domain mediates PIX dimerisation and translocation to 
the membrane ruffles. The in vitro exchange activities of these 	and 2PIX (this 
isoform lacks the coiled coil) were comparable suggesting that their phenotypic effect 
in HeLa cells were spatially regulated. 
 
Spatial regulation of PAK activity by PIX 
Cdc42, Rac1 and PAK1 were activated when cells were plated on fibronectin (Price et 
al., 1998) and this is suggested to involve specific coupling between Rac1 and PAK at 
the FCs of adherent cells (del Pozo et al., 2000). Since 1PIX and PAK are enriched 
at Cdc42- type FCs, 1PIX exchange activity is likely to be coupled to PAK 
activation in this Cdc42 setting (Manser et al., 1998).  
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The direct Nck- and PIX binding to PAK coupled PAK to receptor tyrosine kinase 
signalling pathways (Yoshii et al., 1999). Direct binding of PIX to the p85 subunit 
(PI3-K) is reported to be obligatory for activation of PIX’s GEF activity upon PDGF 
stimulation. However the region responsible for the binding between p85 and PIX is 
not documented. A p85 mutant (lacking interaction with p110 of PI3-K) or Nck SH2 
mutant (no binding to tyrosine phosphorylated receptor or Cas) abrogated activation of 
PAK in this PDGF pathway. 
 
Opposing effects of PIX in PAK kinase activation have been reported. In one report, 
PIX failed to activate PAK1 although a truncated PIX comprising of SH3-DH-PH 
domains did activate PAK1 in the presence of excess wildtype Cdc42; this activation 
was dependent on both PIX exchange activity and PIX-PAK interaction (Daniels et al., 
1999). A conflicting report on PAK3 activation by COOL2 (PIX) but not COOL1 
(PIX) suggested that COOL1 has a unique inhibitory sequence (Feng et al., 2002) 
depicted as insert ‘I’ in 1 and 2PIX splice forms (Figure 1.6, page 16). Finally, a 
comprehensive study suggested 1PIX, 2PIX, 1PIX (1-555) and 1PIX (80-647) 
actually reduced PAK activation by wild type Cdc42 (Koh et al., 2001). Hence the 
literature is rather confusing with regard to the relationship between PAK and PIX.  As 
I will show in this thesis (Chapter 5, Figure 5.1), PIX has no significant PAK activating 
activity under over expression conditions despite its exchange activity towards Rac1. 
 












Figure 1.6: Domain organisation in mammalian PIX members. Abbreviations: CH, 
Calponin Homology; DH, Dbl Homology; PH, Pleckstrin Homology. The percentages 
represent domain homology between and 1PIX. The 2PIX splice form does not 
have the coiled coil and is replaced with a serine-rich stretch. Inserts I and II are 
present in PIX isoforms and they contain 30 and 60 residues respectively. This figure 
is reproduced from Koh et al., 2001. 
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IV GIT/PKL/APP family members are coupled to PIX and PAK 
 
PIX is tightly coupled to a 90 kDa protein GRK interactive target (GIT1) that was first 
reported as a G-protein coupled receptor kinase binder in a yeast two hybrid screen 
(Premont et al. 1998); GIT1 was suggested to inhibit 2-adrenergic receptor signalling 
in an Arf GAP dependent manner. The second member (human GIT2) was identified in 
a database search (Premont et al., 2000). GIT homologues are named differently (PKL 
or APP) based on its method of purification; the sequence identity among these 






Figure 1.7: Amino acid sequence identity among GIT, PKL and APP members. 
GIT1 and GIT2 are of human origin and they share 64% amino acid sequence identity. 
PKL, APP1 and APP2 are of chicken origin. PKL (chicken homologue) is 89% 
identical to GIT2 and 65% identical to GIT1. APP1 (chicken homologue) shares 87% 









   18
 
Paxillin kinase linker (PKL) is the chicken homologue of GIT2 (Turner et al, 2001) 
and interacted directly with paxillin Turner et al., 1999. This interaction was 
proposed to bridge PIX and PAK to paxillin-containing FCs; a PKL mutant (paxillin 
binding defective) was unable to localise to these sites and also abrogated PAK 
localisation (Brown et al., 2002). De-regulating PKL-paxillin  interaction produced 
multiple lamellipodia in cells plated on fibronectin and this was correlated to Rac1 
activation but directional cell movement was impaired (West et al., 2001). GIT1-
paxillin  interaction was implicated in FC turnover in microinjection studies (Zhao et 
al., 2000b). A membrane-targeted GIT1 fragment consisting of the paxillin-binding 
domain was sufficient to cause FC loss and cell retraction. FAK also bound directly to 
GIT1 and phosphorylated GIT1; FAK and GIT1 are thought to act co-operatively in FC 
turnover.  
 
ArfGAP-putative, PIX-interacting, paxillin-interacting protein 1 (APP1) is the chicken 
homologue of GIT1, and was co-purified with PIX and PAK with the Rac1B.GTP 
column (Di Cesare et al., 2000).  Mutations in the Arf GAP domain of APP1 
partitioned APP1 and protein partners to Rab11-positive membrane compartments and 
this could be regulated by Rac1B. APP1 exhibited no Arf GAP activity towards Arf6 
(Matafora et al., 2001). APP1 is implicated in the regulation of membrane trafficking 
events for Rac1B dependent cellular processes i.e. cell migration and neurite outgrowth 
(de Curtis, 2001, Albertinazzi et al., 2003). 
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Structural features of Arf GAP members and physiological functions 
These GIT, PKL and APP proteins are part of the expanding Arf GAP family (Figure 
1.8, page 20). Arfs are GTPases and are involved in membrane recycling and some 
aspects of cytoskeletal re-arrangement (Randazzo et al., 2000). These members feature 
a tandem Arf GAP- and anykrin repeat domains (except for Arf GAP1, yeast Gcs1 and 
Glo3). These Arf GAP domains bear no sequence or structural similarity with Rho-and 
Ras-GAPs. The Arf GAP domain contains a zinc finger co-ordinating motif and an 
invariant arginine residue (Figure 1.9, page 20). In the PAP crystal structure 
(Mandiyan et al., 1999), the Arf GAP domain is comprised of a central 3-stranded -
sheet flanked by 5 -helices, and a Zn 2+ ion is co-ordinated by the four cysteine 
residues present in the CxxCx16CxxC motif. Each ankyrin repeat forms a helix-turn-
helix-loop (except the first repeat) where the first two repeats form an extensive 
interface with the Arf GAP domain.  Mutation of the putative catalytic arginine to 
lysine drastically reduced its GAP activity; Arf GAP1, ASAP1, ACAP1/2  depended 
on this arginine residue for their catalytic activities (Szafer et al., 2000, Randazzo et 
al., 2000, Jackson et al., 2000). This arginine conforms to the ‘arginine finger’ model 
assigned to many GAPs for small GTPases (Scheffzek et al., 1998), it forms hydrogen-
bonds with the phosphate of GTP and stabilises the transition state during GTP 
hydrolysis. Some members, including ASAP1 (Brown et al., 1998, Kam et al., 2000), 
ACAP1/2 (Jackson et al., 2000), PAP (Andreev et al., 1999) and ARAP1/2/3 (Miura et 
al., 2002, Krugmann et al., 2002) have the pleckstrin homology (PH) domains. The PH 
domain is involved in phosphoinositide binding and regulation of GAP activity in vitro 
(Figure 1.10, page 21). The minimal module for functional GAP activity appears to 
require the PH-Zinc finger-ankyrin repeats (PZA). 
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Figure 1.8: Arf GAP family members. Most members contain tandem Arf GAP 
domain (blue) and ankyrin repeats (green) , some have PH domain (red) and are 
collectively known as PZA (PH, Zinc finger, Ankyrin repeats) module. This figure is 





Figure 1.9: Sequence alignment of the Arf GAP domain. Sequence alignments of 
GIT1 (residue 6-44), ARAP1 (residue 305-343), ASAP1 (residue 464-502), PAP 
(residue 431-469), Arf GAP1 (residue 17-55) and ACAP (residue 409-447). The Arf 
GAP domain is characterised by the cysteine motif (CxxCx16CxxC) and the arginine 
finger (R). 
10 20 30
P R A E V C A D C S A P D P G W A S I S R G V L V C D E C C S V H R S L G R H1 1
A P N R F C A D C G A P Q P D W A S I N L C V V I C K R C A G E H R G L G A G1 2
P G N D I C C D C G S S E P T W L S T N L G I L T C I E C S G I H R E M G V H1 3
T G N D V C C D C G A P D P T W L S T N L G I L T C I E C S G I H R E L G V H1 4
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Decoration 'Decoration #1': Shade (with solid black) residues that match the
Consensus exactly. 
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Arf GAP member  Arf Specificity PI Dependence 
ARAP1    Arf1 and Arf5  PI(3,4,5)P3 
ARAP3    Arf6   PI(3,4,5)P3, PI(3,4)P2 
ASAP1    Arf1 and Arf5  PI(4,5)P2, PA 
PAP    Arf1 and Arf5  PI(4,5)P2 
ACAP    Arf6   PI(4,5)P2, PA 
 
Figure 1.10: Phosphatidylinositol (PI) stimulated in vitro GAP activity. Arf 
specificity of Arf GAP members; GAP activities are regulated by PI and PA 
(phosphatidic acid). 
 
These Arf GAP members appear to exhibit other activities beside their GAP activity. 
This is illustrated by the ability of yeast Gcs1 to restore growth of the temperature-
sensitive Arf1 mutant at restrictive temperature, suggesting that Gcs1 in fact acts 
downstream of Arf1 (Zhang et al., 1998). The related Glo3 has been shown to prime v-
SNARE for its interaction with Arf1 and coatomer (for vesicle formation), in a GAP-
independent manner (Rein et al., 2002). This allows v-SNARE inclusion into vesicle 
and subsequent fusion with target membrane. Thus the GAP domain is integral of Arf 
function rather than down regulating Arf signalling. A similar situation is seen with n-
chimaerin which exhibited GAP activity towards Rac1 in vitro, but co-operated with 
Rac1 and Cdc42 to induce lamellipodia and filopodia formation respectively (Kozma 
et al., 1996). The multiple domains of these Arf GAP members do suggest that they 
have protein-scaffolding activity for signalling pathways integration. The importance 
of GAP activity per se (and Arf substrate specificity) in their physiological functions of 
Arf GAP members remains to be seen. 
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GIT1 and GIT2 isoforms 
GIT1 and GIT2 isoforms are co-linear in their domain organisation (Figure 1.11). The 
amino terminal half of GIT1 and GIT2 are 84% identical and contain the Arf GAP, 
ankyrin repeats (ANK) and the Spa2 homology domain (SHD-I). The carboxyl 
terminus half contains the leucine zipper (LZ, 52% identity), a variable region (34% 
identity) and the region implicated in paxillin  binding (paxillin  BD, 77% identity). 
These regions are demarcated by the existing restriction sites that were used for the 










Figure 1.11: Organisation of GIT1 domains. The Arf GAP and ankyrin repeats are 
characteristic domains of the Arf GAP family members, the SHD-I (Spa2 homology 
domain) is implicated in PIX-binding, the leucine zipper, and the extreme carboxyl 
terminus is involved in paxillin binding. The numbering refers to the amino acid 
residue and the restriction sites are present in the cDNA. 
Arf                   Ankyrin                SHD-I        Leucine                                Paxillin 
GAP                 repeats                                      zipper                                 binding
100            200           300            400            500           600            700
Hind III       BgI II                  Xho I             Apa I                 Sma 1
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V Objectives of my research  
 
GIT1 and 1PIX are constitutively-associated protein partners (Bagrodia et al., 1999, 
Zhao et al., 2000), therefore GIT1 and PIX are anticipated to regulate PAK. PAK is 
activated by Cdc42 or Rac1 (Manser et al., 1994), and 1PIX is implicated in 
recruiting PAK to the Cdc42-type FCs for activation (Manser et al., 1998). PIX 
exhibits exchange activity towards Rac1 and most of the research efforts were focused 
on PAK activation but without consensus results. Three disparate research for GIT1 
and homologues were addressed. Turner and co-workers studied the role of PKL-
paxillin  interaction for recruiting PKL and protein partners to FCs. Zhao et al. 
(2000b) have shown that GIT1-paxillin  interaction promoted FC turnover that was 
necessary for cell migration. De Curtis and co-workers implicated the Arf GAP domain 
of APP1 for membrane trafficking events in Rac1B-dependent neurite outgowth. Till 
now, the role of PAK and its regulation (kinase activation per se) by the GIT1/PIX 
protein complex remain unclear, it is not known how the dynamics of GIT1 and PIX 
affect PAK. Is PAK activity required in the GIT1-regulated cellular processes such as 
neurite outgrowth? 
 
The experiments in this thesis were designed in mind to address two regulatory aspects 
of PAK signalling by GIT1 and PIX. They include the role of GIT1 and its protein 
interactions for both FC recruitment and kinase activation of PAK. The effect of 
activated PAK on GIT1 (GIT1 is a PAK substrate) and the possible mechanism of the 
protein complex turnover at FC were also explored. 
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VI Experimental outlines  
 
In chapter 3, immuno-precipitation and immuno-fluorescence staining experiments 
were carried out to establish GIT1, 1PIX and PAK (and activation status) as a 
physiological protein complex in cell lines. GIT1 mutants were generated to analyse its 
interaction with 1PIX and its regulation over oligomerisation for targeting to FCs. 
GIT1 phosphorylation by PAK was analysed as a possible means to turnover GIT1 
protein complex at FCs.  
 
In chapter 4, GIT1-paxillin  interaction was analysed; GIT1 deletion mutants were 
used to uncover possible intrinsic inhibition on paxillin  binding function, point 
mutations were also generated in the paxillin  binding domain. The role of the 
ArfGAP domain was analysed for GIT1 targeting to FCs. A novel GIT1-PKA 
interaction was found and analysed for PKA phosphorylation effect on GIT1 
oligomerisation. 
 
In chapter 5, the potential role of GIT1 and 1PIX in PAK activation was 
investigated with COS-7 cell expression system transiently transfected with plasmids 
encoding GST tagged PAK (GST-PAK), Flag- or Ha tagged GIT1 and Flag- or Ha 
tagged 1PIX. The two criteria to assess the kinase activity of PAK kinase were 
substrate phosphorylation (generic substrate or PIX) as well as mobility shift of PAK 
(phosphorylation-induced conformational changes). The recently available of PAK 
site- and phosphorylation-specific antibodies allowed specific analysis of PAK auto-
phosphorylation sites (serine 144 and threonine 422) that are important for kinase 
activation (Chong et al., 2001). 
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Chapter 2  Methods and Materials  
 
Cloning of GIT2 (368-759), PKA and RII into mammalian expression PXJ 
plasmid. GIT2 (368-759) was amplified from cDNA (kindly provided by Premont 
R.T.) with a 5’ oligo flanked by a XhoI site (GAT CTC GAG AAC GAT CAG CCC 
GAC TAT) and a 3’ oligo with BamHI site (GAT GGA TCC TCA GTT GTT GTT 
CTC TTT GGT GGT), and cloned into XhoI and Bgl II sites of PXJ-Flag plasmid. 
PKA catalytic domain was amplified from an EST clone with a 5’ oligo flanked by a 
BamHI site (GAT GGA TCC ATG GGG AAC ACT GCG ATC) and a 3’ oligo with 
XhoI site (GAC CTC GAG TCT CCT CCC TAA AAT TCA), and cloned into PXJ-Ha 
and PXJ-GST plasmids. PKA regulatory domain RII was amplified from a mouse 
cDNA library (Clonetech), with a 5’ oligo flanked by a BamHI site (GAT GGA TCC 
ATG AGC CAC ATC CAG ATC CCG CCG) and a 3’ oligo with XhoI site (GAT 
CTC GAG CTA CTG CCC GGG GTC CAT CAG ATC), and cloned into PXJ-Ha 
plasmid.  
 
Cloning of Arf1 and Arf6 into PXJ plasmid with a 3’ His tag. A six-histidine tag 
was engineered into PXJ plasmid at the XhoI site. Arf1 and Arf6 were cut from 
pET37-Arf1 and –Arf6 clones with Nde1 and XhoI enzymes, the Nde1 sticky end was 
filled. These Arf1 and Arf6 constructs were then cloned into PXJ plasmid cut with 
EcoRI (filled) and XhoI sites with 3’ His tag. 
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Mammalian expression constructs & mutagenesis. Plasmid pXJ-GST PAK, pXJ-
Flag GIT1 and pXJ-HA 	PIX are as described previously (Manser et al., 1997 & 
1998, Zhao et al., 2000). Plasmids encoding GIT1, 	PIX and PAK carrying the 
various amino acid substitutions were constructed using the Quickchange protocol 
(Stratagene) under the manufacturer’s conditions unless otherwise specified. Each new 
mutant was sequenced at IMCB central sequencing facility. GIT1, GIT2 and 1PIX 
deletion-mutants were generated using internal restriction sites in the cDNA.  
 
List of oligos for Quickchange protocol (Stratagene). Only the sense strands are 
shown, the mutations are underlined and restriction sites are indicated. 
 
GIT1 SHD-I mutations 
 
R283E/L284F 
                         EcoRI 
CAA GCA CTC AGC AAC GAA TTC TTT GAG GAG CTC GCC 
  
E286S/E287R 
                       XbaI 
AGC AAC CGG CTC TTT TCT AGA CTC GCC ATG GAT GTG 
 
D291K/V292L 
                                   HindIII 
GAG GAG CTC GCC ATG AAG CTT TAT GAC GAA GTG GAC 
 
D294K/E295R  
                                  MluI 
GCC ATG GAT GTG TAT AAA CGC GTG GAC CGG AGA GAA 
    
E295A 
 




CTC GCC ATG GAT GTG TAT GCC GCA GTG GAC CGG AGA GAA 
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R298L/R299E  
                                              XhoI 
TAT GAC GAA GTG GAC CTC GAG GAA AAT GAT GCA GTG 
 
D355K/I356L 
                                         HindIII 
GCC ACC TTG ATC ATC AAG CTT CTC AGT GAG GCC AAA CGG 
  
S358K/E359R  
                                    AflII 
C ATC ATC GAC ATC CTT AAG CGC GCC AAA CGG AGG CAG 
 
R362L/R363E   
                                              XhoI 
CTC AGT GAG GCC AAA CTC GAG CAG CAG GGC AAG AGT 
 
1PIX (defective GIT1 binding) mutation  
  
I539P/E540G 
                       Sma1 
CAG ATC CTG AAG GTT CCC GGG GCT TAC TGC ACA AGT 
  








GG GAC CGC CAG GCC TTC GCT ATG TAT GAG CCA GGC TCC 
 












G GTC ACC AAG AAC ATT CAG GAG GGA TTG CGG GCA GCC CAG GAG   
  
























GCA GCC CAG GAG TTC AAA GCT GAC AGC TTT GTG CCC TGT 
  
 
GIT2 helix mutations 
L657G                 Afl II 
ATC ACC AAA AAC ATA CAG GAG GGC TTA AGA GCA GCC CAA GAA  
 
L658G 
ACC AAA AAC ATA CAG GAG CTC GGA AGA GCA GCC CAA GAA AAT 
 
GIT1 Arf GAP mutations  
 
R39K 
   
GAG TGC TGC AGT GTG CAC AAG AGC CTG GGA CGA CAC ATC 
 
C11/14G (by conventional method)           
          Nar I 
GTG GGC GCC GAC GGC AGC GCC CCT GAC CCT         
           
         Nar I 
GTC GGC GCC CAC CTC CGC TCG CGG CCC 
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GIT1 ankyrin repeats mutation 
G178P/Q179R (by conventional method)   
          Avr II 
GCA CCT AGG ACA CTG CAG GCT GAG CTG 
 
                   Avr II 
 CAG TGT CCT AGG TGC CTT GGC AGC CAC GT 
 
Arf 6 mutation 
Q67L 
                   Bsa I 
G TGG GAT GTG GGC GGT CTC GAC AAG ATC CGG CCG 
  
T27N (by conventional method) 
          BamH I 
TG CGG ATC CTC ATG CTG GGC CTG GAC GCA GCC GGC AAG AAT ACG  
 
ATC CTG TAC AAG 
 
Conventional method of mutagenesis. This method involved two separate PCR 
reactions. One PCR reaction included the forward oligo (F2) and another oligo carrying 
both the intended mutation and restriction recognition site (as indicated). The other 
PCR reaction included an oligo carrying the mutation and the restriction recognition 
site and the reverse oligo (R2). The two PCR products were spliced together via the 
restriction site and served as template for an additional PCR round with F2 and R2 
oligos. F2 and R2 oligos anneal to 5’ and 3’ ends of the multiple cloning sites (MCS) 
respectively in PXJ40 plasmid. 
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GIT1 amino terminus deletion mutants. Deletion mutants were generated with 
restriction sites in GIT1 cDNA, Kpn1 site is present in the 3’ non-coding sequence and 
routinely used for 3’ cloning. GIT1 (119-770) was cloned with HindIII, GIT1 (254-
770) was cloned with Bgl II (into BamHI of plasmid) and GIT1 (376-770) was cloned 
with XhoI.  These were in correct reading frame to the 5’ tag.  
 
GIT1 internal deletion mutants. GIT1  repeat 1 ( 282-325); GIT1 (1-281) was 
amplified with F2 and reverse oligo flanked by a Hinc II site (GTC GTT GAC GCT 
GAG TGC TTG TAG CTT), and cloned into Hpa I site at 326/327 of GIT1. The HpaI 
site at residue 326/327 (silent mutation) was generated with Quickchange protocol. 
GIT1  repeat 2 ( 328-375); GIT1 (376-770) was amplified with forward oligo 
flanked by a Hpa I site (GAC GTC AAC CTC GAG CTG TCT GCA CGG) and R2, 
and cloned into Hpa I at 326/327 of GIT1. GIT1  leucine zipper ( 424-480); GIT1 
(1-423) was amplified with F2 and reverse oligo flanked by a XbaI site (ATC TCT 
AGA GGA GTC CAT GCT CCT GGC), GIT1 (481-770) was amplified with forward 
oligo flanked by a XbaI site (GAT TCT AGA CAG CCA CCA GGA CCA GTG) and 
R2. Both amplified fragments were digested with Xba I and ligated to remove the 
intervening 424-480 sequences. GIT1  helix ( 663-674); GIT1 (1-662) was 
amplified with F2 and reverse oligo flanked by a DraI site (CGG GCA GCC CAG 
GAG TTT AAA CAT GAC AGC TTT GTG), and cloned into Dra1 site at 675/676 of 
GIT1. The Dra1 site at residue 675/676 (silent mutation) was generated with 
Quickchange protocol. 
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GIT1- and GIT2 carboxyl terminus deletion mutants. GIT1 and GIT2 deletion 
mutants were generated through internal restriction sites in their cDNAs. GIT1 (376-
759) using the PvuII site, GIT1 (376-707) using the FspI site, GIT1 (376-646) using the 
SmaI site. GIT1 (1-504) was sub-cloned using the ApaI site, into SK plasmid and 
subsequently transferred to PXJ plasmid with 3’ KpnI site. GIT2 (368-729) using the 
PvuII site, GIT2 (368-711) using the PstI site and GIT2 (368-623) using the KpnI site. 
 
Cloning of Arf1 and Arf6 into bacterial expression plasmid. Arf1 was amplified 
with 5’ oligo flanked by a Nde1 site (GAT CAT ATG GGG AAT ATC TTT GCA), 3’ 
oligo flanked by a Xho1 site (GCC CTC GAG CTT CTG GTT CCG GAG CTG). Arf6 
was amplified with 5’ oligo flanked by a Nde1 site (GAT CAT ATG GGG AAG GTG 
CTA TCC), 3’ oligo flanked by a Xho1 site (GAT CTC GAG GGA TTT GTA GTT 
AGA GGT) and cloned into pET37 (+) plasmid (Novagen) with 3’ His tag. 5’ Nde1 
cloning allowed translation at the ATG initiation codon of Arf sequence.  
 
Induction of recombinant Arf1- and Arf6 expression and purification. pET37-Arf 
and PGEX4T1-NMT1 plasmids were co-transformed into BL21 (DE3) bacterial strain, 
plasmid selection was with kanamycin (for pET37-Arf) and ampicilin (for PGEX4T1-
NMT1). Bacterial culture was induced with 0.5mM IPTG for Arf- and NMT1- protein 
expressions for 1 hour. Myristic acid (500M final concentration) was then added to 
culture and incubated for further 3 hours at room temperature. NMT1 catalysed 
addition of myristic group to Arf. Arf proteins were tagged at 3’ with His for 
purification with Nickel column. Bacterial cells were lysed with lysozyme @ 1mg/ml 
in buffer (50mM HEPES, 0.3M NaCl, 0.1% TX-100, 5mM MgCl2, 10% glycerol, 
20mM imidazole and 1mM PMSF) on ice and sonicated. Arf proteins were tagged at 3’ 
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with 6xHis for purification with Nickel column and washed with buffer (no lysozyme), 
proteins were eluted with buffer containing 50mM imidazole. Purified Arf proteins 
were dialysed overnight at 4oC with 2 changes of PBS.  
 
GTP loading of recombinant Arf1 and Arf6 proteins. Purified Arf protein was 
incubated in exchange buffer (25mM MOPS, pH7.4, 100mM KCl, 1mM MgCl2, 
[33P]-GTP, 30mM DMPC and 1% sodium cholate) and cold GTP (10 M final) at 
30oC for 45 minutes.  
 
Cloning of ‘PAK synthetic substrate’ into bacterial expression PGEX4T1 
plasmid. These oligos were treated with polynucleotide kinase and ATP to 
phosphorylate the 5’ OH group. Then they were annealed and cloned into PGEX4T1 
plasmid using BamHI and EcoR I sites. (5’ GA TCC GGT GAT AAA CGT GAT TCT 
ATG GTT GGT GCT CCC GGG GAC AAG CGC GAT AGC ATG GTC GGC GCC 
CCC TG 3’) and (3’ AA TTC AGG GGG CGC CGA CCA TGC TAT CGC GCT TGT 
CCC CGG GAG CAC CAA CCA TAG AAT CAC GTT TAT CAC CG 5’) 
 
[35S]-methione in vitro translation & protein-protein interaction. The mammalian 
expression vector allows for in vitro translation using T7 RNA polymerase in rabbit 
reticulolysate (Promega). Reaction was carried out with 1g DNA per 25l lysate and 
incubated at 30oC for 45 minutes. The reaction was diluted with 200 l phosphate 
buffered saline (PBS) containing 1% triton X-100 for anti-Flag M2 sepharose (Sigma 
chemicals) immuno-precipitation or pull down experiments. 
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Cell transfection, fractionation and immuno-precipitation. COS-7 cells at 70-80% 
confluency (60mm culture dish) were starved 1 hour with serum-free DME (SF-DME) 
prior addition of DNA-lipofectamine (Gibco BRL). For each dish 4g total DNA (in 
200l SF-DME) was mixed with 25g lipofectamine reagent (in 200l SF-DME) and 
incubated for 30 minutes at room temperature. This mix was diluted with 1.6ml SF-
DME and added to the cells.  After 3 hours fetal bovine serum (FBS [Gibco BRL]) was 
added to a 1% final concentration. Transfected cells were harvested after 18-20 h by 
scrapping in ice cold lysis buffer (400l of 50mM HEPES, pH 7.3, 150mM NaCl, 
1.5mM MgCl2, 1mM EDTA/EGTA, 20mM -glycerophosphate, 5% glycerol, 1% 
triton X-100, 1mM DTT and a protease-inhibitor cocktail [Roche]). Cells were broken 
by 10 passages through a 29 gauge insulin syringe before clarification at 14,000g for 10 
min. Pellets were washed with lysis buffer for 15min on ice, re-pelleted and suspended 
in appropriate volume of 1x SDS sample loading buffer. For SDS-PAGE samples were 
heated (3 min at 95C) run immediately, and tranferred to PVDF membranes for 
western analysis. For immuno-precipitation 200l lysate was incubated with 25l of 
anti-Flag M2 sepharose (Sigma chemicals), and the beads washed with 1ml lysis 
buffer. For GST-PAK purification, 400l lysate was incubated with 50l glutathione-
agarose (Pharmacia) and the amount of recovered protein quantified with anti-PAK 
antibodies. 
 
Bis(Sulfosuccinimidyl) suberate (BS3) cross-linking. Transfected COS-7 lysates or 
recombinant proteins @0.5mg/ml (affinity tag was cleaved off with thrombin) were 
incubated with BS3 at final 0.4mM concentration on ice for 30min.  
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Immunocytochemistry, microscopy and image-processing. HeLa cells were plated 
on cover-slips in 30mm culture dishes and grown to 60% confluency. Plasmid DNA 
(1g per 5l lipofectamine reagent) was mixed in 200l SF-DMEM for 30 minutes and 
then diluted to 1ml for addition to cells. After 2 hours, FBS (Gibco BRL) was added to 
1% final concentration. After 16h cells were fixed in 3% paraformaldehyde for 5 
minutes, and permeabilised (10 min) with PBS containing 0.5% triton X-100. Primary 
antibodies were added (100l per coverslip in PBS + TX-100) and incubated for 2 
hours (30oC). Secondary fluorescent (Molecular Probes) antibodies were incubated for 
1 hour before mounting (Immunon) the cover slips on glass slides. Primary antibodies 
were rabbit anti-GFP (Molecular Probes), mouse anti-vinculin (Sigma chemicals) and 
anti-paxillin (Transduction Laboratories) and were used at 1:200 dilutions. Secondary 
antibodies were coupled with Alexa 488 or Alexa 546 dyes (Molecular Probes). For 
fluorescence observation these secondary antibodies were visualized on a Ziess 
Axioplan II using a Plan-Apochrom at 63x/1.40 objective, and images collected on a 
Coolsnap HQ charged coupled device (Photonics).  
 
Materials  
Antibodies: mouse anti-Flag M2 (Sigma chemicals), rabbit anti-Ha (Zymed), rabbit 
anti-PAK C20 (Santa Cruz), rabbit anti-GIT1 (Santa Cruz-13961) and rabbit anti-
RhoGDI (Transduction Laboratories) were used at 0.5g/ml for western blotting (WB). 
Rabbit anti-phospho-PAK1 antibodies directed towards Ser144, Ser199/204 and 
Thre423 (Cell Signalling) were used at 1:1000 dilution for WB.  Secondary antibodies 
were as follows: Protein A-HRP (1:10,000 for WB), anti-rabbit IgG HRP (1:4,000 for 
WB) and anti-mouse IgG HRP (1:4,000 for WB) were from Jackson Laboratories. 
Others: Bis(Sulfosuccinimidyl) suberate (Pierce) at 0.4mM for cross-linking.  
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Chapter 3 GIT1 and 1PIX are important binding partners of PAK 
 
GIT1 and 1PIX proteins were initially identified in PAK immuno-precipitates as 
[33P]-labelled protein bands and probable PAK substrates (Manser et al., 1997).  
Subsequently, GIT1/PIX proteins were affinity purified with the regulatory domain of 
PAK. The PAK-PIX interaction is mediated by the third proline-rich motif of PAK 
with the cognate SH3 domain of 1PIX (Manser et al., 1998). The PIX binding motif 
is found in -, - and -PAK but not in the non-conventional PAK 4/5/6 species (Jaffer 
and Chernoff, 2002). GIT1 binds indirectly to PAK via PIX (Zhao et al., 2000b). 
 
I In vivo GIT1/1PIX/PAK protein complex 
Expression of PAK/PIX/GIT proteins in COS-7, HeLa and NIH3T3 cell lines were 
examined by Western analysis (Figure 3.1, page 36). As COS-7 and HeLa cells were 
routinely used in transient transfection experiments, it is important these proteins are 
present in these cell lines for the data to be meaningful. PAK was most abundantly 
expressed in NIH3T3 cells (panel A); at this exposure the anti-PAK antibody also 
cross-reacted with PAK in all three cell lines and possibly PAK in NIH3T3. PAK 
expression was restricted to NIH3T3 cells (panel B), but PAK was present in all three 
cell lines with highest expression in COS-7 cells (panel C). The PIX SH3 domain is the 
most conserved region (90% identity) among - and PIX isoforms (Koh et al., 2001) 
and was used to raise antibodies (Manser et al., 1998). The PIX proteins in these cell 
lines were predominantly 1PIX (panel D), since they migrated at an apparent size of 
72kDa corresponded to 1PIX (Koh et al., 2001). The GIT isoform present in these 
cell lines was probably GIT1 (panel E). However anti-GIT1 antibody cross-reactivity 
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with GIT2 cannot be ruled out since there is 77% sequence identity in the region used 
to raise the antibody. Currently, there is no specific anti-GIT2 antibody available 
commercially. 
 
Figure 3.1: PAK isoforms, 1PIX and GIT1 in cell lines. Cell line protein lysates 
(50g of C; COS-7, H; HeLa, N; NIH3T3) were resolved with 9% SDS-PAGE gel for 
Western blot (WB) analysis. Anti-PAK antibody was raised with the amino-terminus 
regulatory sequences of PAK (Manser et al., 1995) and cross-reacted with PAK as 
well, NIH3T3 had the highest expression level of PAK (A). Anti-PAK antibody 
showed restricted PAK expression pattern in NIH3T3 only (B). Anti-PAK (Teo et 
al., 1995) revealed protein expressions in all three cell lines (C), which is also reflected 
by the anti-PAK WB in panel A. Anti-PIX antibody was raised against the conserved 
SH3 domain among PIX isoforms (Manser et al., 1998) and anti-GIT1 was raised 
against the GIT1 (646-770) (Zhao et al., 2000b), 1PIX and GIT1 were the 
predominant isoforms in these cell lines (D & E).  
69 -
WB :       Anti-PAK                        Anti-PAK                        Anti-PAK
  68 kDa                               65 kDa                               62 kDa
 WB :     Anti-PIX SH3                      Anti-GIT1
  72 kDa                               85 kDa
Lysate :    C       H       N                     C       H      N                      C      H      N
< 
< 
<  < 
C       H      N                     C       H      N
1 > < GIT1
A                           B                          C
D                           E
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This PAK/PIX/GIT protein complex was immuno-precipitated from NIH3T3 lysate 
with four different antibodies (Figure 3.2). Both GIT1 and 1PIX proteins were 
detected in PAK immuno-precipitate (lane 1), whereas 1PIX- (lane 2) and GIT1- 
(lanes 3 & 4) immuno-precipitates contained only these two components, and PAK 
was not detected. The absence of PAK in these immuno-precipitates probably reflects 
two cellular pools of GIT1/PIX complex in NIH3T3; one pool was complexed to 




Figure 3.2: Immuno-precipitations of PAK, 1PIX and GIT1 protein complex 
present in NIH3T3 lysate. Protein immuno-precipitations of NIH3T3 lysate were 
carried out with four antibodies as depicted. NIH3T3 contained predominantly PAK, 
1PIX and GIT1 isoforms (Figure 3.1).  PAK immuno-precipitate (lane 1) contained 
1PIX and GIT1. 1PIX- (lane 2) and GIT1 immuno-precipitates (lanes 3 & 4) 
contained both GIT1 and PIX, but PAK was not detected. 
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Fibroblast spreading on fibronectin has been reported to involve Cdc42 and Rac1 and 
PAK was activated during this process (Price et al., 1998). 1PIX and PAK were 
enriched at Cdc42-type FCs in HeLa cells where 1PIX mediated PAK recruitment to 
these sites (Manser at al., 1998). Therefore, HeLa cells were plated and allowed to 
spread on fibronectin for GIT1 and 1PIX intracellular localisation analysis (Figure 
3.3, page 39). HeLa cells (epithelial origin) took longer to adhere and spread on 
fibronectin than fibroblasts. GIT1 and 1PIX were colocalised at the cell peripheral 
structures (panels A & B), and 1PIX was clearly associated with the small peripheral 
FCs stained with the paxillin marker (panels C & D). The cell was also stained positive 
with an anti-phospho specific antibody raised against the serine 198/203 auto-
phosphorylation sites of PAK (panel E), suggesting PAK was active when it 
colocalised with 1PIX at these FCs (panel F). Thus GIT1 and 1PIX were present 
together with PAK at these Cdc42- and Rac1-type FCs during cell spreading.  
 
Constitutively active Cdc42 (G12V) drives peripheral FCs formation, similar to those 
seen during cell spreading. In HeLa cells transfected with this Cdc42 mutant (Figure 
3.4, page 40), PIX and active PAK were both detected similarly at these peripheral FCs 
as in the cell spreading experiment.  
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A : anti-GIT1                B : anti-PIX                   Merged 
 
 










Figure 3.3: GIT1, 1PIX and active PAK were present at peripheral FCs during 
cell spreading. HeLa cells were plated and allowed to spread on fibronectin-coated 
coverslip in serum-free medium before cell fixation. Cells were immuno-stained 
(horizontal panels) for endogenous GIT1 (A) and 1PIX (B) or 1PIX (C) and paxillin 
(D) or with anti-phospho PAK (E) and PIX (F). In the merged images of green and red 
channels (processed by Photoshop software), GIT1 and 1PIX were concentrated at 
peripheral structures (A & B). 1PIX was present at these peripheral paxillin-
containing FCs (C & D) and active PAK (E) was associated with 1PIX (F) at these 
sites.  
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G : anti-PIX                 H : anti-Vinculin         Merged  
    
 
  < 
 
 







Figure 3.4: 1PIX and active PAK were present at Cdc42-type FCs. HeLa cells 
were transfected with constitutively active Cdc42 (G12V); transfected cells are 
indicated with an asterisk. Cells were immuno-stained for endogenous 1PIX (G) and 
vinculin (H), or with anti-phospho PAK (I) and paxillin (J). 1PIX (G) and active PAK 
(I) were concentrated in Cdc42-type FCs. Either paxillin or vinculin was used as 
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II Analysis of GIT1-1PIX interaction 
 
The PIX binding domain (PIX BD) in GIT1 was mapped to the SHD-I (Zhao et al., 
2000b). The SHD-I contains two direct repeats in which a number of conserved 
residues were substituted with opposite charged amino acids to analyse their potential 
role for 1PIX interaction (Figure 3.5, page 42). Flag-tagged full-length GIT1 wild 
type and mutants were co-expressed with Ha-tagged 1PIX in COS-7 cells; Flag-
GIT1s were immuno-precipitated (panel A). Of the eight GIT1 mutants (m1-m8), only 
one mutant (m4 in the first repeat, D294K/E295R) failed to co-precipitate 1PIX. The 
corresponding mutation (m7) in the second repeat retained 1PIX binding, suggesting 
that the first repeat might be responsible for 1PIX binding. The other GIT1 mutants 
were comparable to wild type in1PIX binding. 
 
This analysis was repeated with in vitro translation of proteins where the expression 
level was lower than in COS-7 cells (panel B, page 43). Some of the GIT1 mutants 
showed reduced binding to 	PIX although this was not seen in the COS-7 over-
expression system. GIT1 m3-m5 mutations in the first repeat and m6 in second repeat 
were affected; other mutants were apparently normal for 	PIX binding.  
 
The GIT1 D294/E295 residues implicated in 1PIX binding were also substituted with 
alanine (panel C, page 43). These GIT1 (E295A) and (D294A/E295A) mutants 
retained weak binding to 	PIX as compared to GIT1 (D294K/E295R) that completely 
abolished 1PIX binding. I conclude that the conserved residues D294 and E295 are 
probable contact residues in GIT1 for binding to 1PIX.  




Figure 3.5: Mutational analysis of GIT1 SHD-I for 1PIX binding. The conserved 
GIT1 residues in these two repeats were chosen for mutational analysis (GIT1 SHD-I 
Repeat Mutations). (A) These full-length Flag-GIT1 and mutants were co-expressed 
witha-1PIX in COS-7 cells and anti-Flag immuno-precipitated from the lysate. The 
GIT1 (D294K/E295R, m4) mutation (boxed) abolished 1PIX binding.  
    wt     m1     m2      m3     m4     m5     m6     m7     m8        WBA
lysate
anti-Flag IP
GIT1 SHD-I Repeat Mutations 
                    m1  m2         m3    m4     m5 
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                                         KL    KR      LE 
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Figure 3.5 (continued): (B) These GIT1 mutants were [35S]-Met labelled with the 
reticulocyte lysate translation system and passed through GST-1PIX (GIT1 binding 
domain, residue 459-555) column. Four GIT1 mutants (m3-m5 in the 1st repeat and 
m6 in 2nd repeat) had reduced 1PIX binding. (C) The GIT1 D294 and E295 residues 
were mutated to alanine (E295A or D294A/E295A) and compared to m4 mutant in 
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The GIT1 binding domain (GIT1 BD) is highly conserved among mammalian PIX 
isoforms (Koh et al., 2001). Therefore, this region of 1PIX was compared to 
Drosophila dPIX to further narrow down residues potentially involved in GIT1 binding 
(Figure 3.6). 1PIX isoleucine I539 and the conserved glutamate E540 were chosen 
since this region is predicted to be  helical and substituted with proline and glycine 
respectively; wild type GIT1 failed to co-precipitate this 1PIX mutant.  
 
 
Figure 3.6: Generation of a1PIX (GIT1-defective binding) mutant. The rat 1PIX 
sequence of the GIT1 binding domain is aligned to Drosophila dPIX sequence to 
identify conserved residues (highlighted in bold font). The 1PIX isoleucine I539 and 
glutamate E540 residues (asterisk) were mutated to proline and glycine respectively. 
Wild type Flag-GIT1, Ha-1PIX and 1PIX (I539P/E540G) mutant were [35S]-Met 
labelled and proceeded with anti-Flag immuno-precipitations. The 1PIX 
























    *
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III Regulation of GIT1 oligomerisation and 1PIX interaction  
The GIT1 amino acid sequence was assessed for coiled coil potential 
(www.ch.embnet.org), one criterion was the presence of a hydrophobic residue at every 
fourth position in the heptad repeat (Zhao et al., 2000b). There are three regions 
predicted to adopt such a coiled coil structure; part of the SHD-I, the leucine zipper 
region (LZ) and part of the paxillin-binding sequence at the carboxyl terminus (Figure 
3.7, page 46). In the alignment of the heptad repeats of the LZ domain (residue 435-
476), the hydrophobic leucine residue (except for second repeat) occupies the fourth 
position in each repeat. To show that this LZ domain mediates GIT1 dimerisation, 
Flag- and Ha tagged GIT1 or GIT1 deletion mutant (424-480, LZ) were co-
expressed in COS-7 cells for anti-Flag immuno-precipitation. Flag- and Ha-GIT1 wild 
type were co-precipitated (lane 1) but not for the GIT1 (LZ) mutant (lane 2), thus 
GIT1 dimerised through the leucine zipper domain.  
 
To assess the degree of GIT1 oligomerisation, GIT1 was covalently cross-linked with 
BS3 and multimeric GIT1 species were resolved by SDS polyacrylamide gel 
electrophoresis (Figure 3.8, page 47). BS3 potentially reacted with amine groups of 
lysine residues interspersed within the LZ domain (refer to heptad repeats alignment in 
Fig. 3.7). Untreated Flag-GIT1 resolved as monomer at 90kDa (lane 1), and BS3 
treated Flag-GIT1 resolved well above the 200kDa marker suggesting it was dimeric or 
larger oligomers (lane 2). As expected, the Flag-GIT1 (∆LZ) mutant resolved as 
monomer (lane 4). For the smaller GIT1 (376-770) which contained the LZ domain, 
the cross-linked species were better resolved as dimer, tetramer and possibly higher 
oligomers (lane 6). Endogenous GIT1 from HeLa lysate was also cross-linked (lane 8) 
albeit not as efficiently as the over-expressed Flag-GIT1 in COS-7 cells. 







Figure 3.7: The GIT1 leucine zipper domain mediated dimerisation. The predicted 
coiled coil regions in GIT1 are shown. Within the LZ domain, the heptad repeats are 
aligned and a leucine residue occupies at the 4th position in each repeat. Two different 
tagged (Flag and Ha) GIT1 or GIT1 leucine zipper deletion mutant (LZ), were co-
expressed in COS-7 cells. Flag-GIT1 co-precipitated Ha-GIT1 (lane 1) suggesting 
homo-dimerisation but the GIT1 (LZ) mutant failed to do so (lane 2).  
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Figure 3.8: GIT1 multimers contained at least dimeric species. Flag-GIT1, Flag-
GIT1 (LZ) and Flag-GIT1 (376-770) were expressed in COS-7 cells. The clarified 
lysates were treated with 0.4mM BS3 cross-linker for 30 min on ice, and resolved in 
parallel with untreated lysates by SDS-PAGE for WB analysis. BS3 treated GIT1 (lane 
2) and GIT1 (376-770) (lane 6) appeared at higher molecular weight than their 
predicted monomeric size (90kDa and 43kDa respectively), while BS3 treated GIT1 
(LZ) remained unchanged (lane 4). Cross-linked GIT1 (376-770) resolved at a range 
between 100-200kDa suggesting of dimeric to tetrameric species (lane 6). Endogenous 
GIT1 in HeLa lysate behaved similarly to Flag-GIT1 upon cross-linking (lane 8).  














1        2        3       4        5       6 
GIT1 :     wt             LZ         376-770
 7     8
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Since GIT1 (376-770) contained a putative  helix at the carboxyl terminus (refer to 
coiled coil profile in Fig. 3.7), this region was also analysed for its role in 
oligomerisation (Figure 3.9). Two GIT1 mutants were generated; the L668G mutation 
that was predicted to destabilise the helix and a deletion (∆663-674, ∆h) of this 
region. Unexpectedly, both proteins were highly cross-linked by BS3 and resolved at 
200kDa and above (lanes 4 & 6) indicating they were predominantly oligomerised. 
This suggests the carboxyl terminal helix might negatively-regulates GIT1 





Figure 3.9: Disruption of a helix structure promoted GIT1 oligomerisation. In 
GIT1 coiled coil profile, the helix at the carboxyl terminus was analysed for its role in 
GIT1 oligomerisation. Flag-GIT1 (L668G) and helix deletion (h) mutants, 
in the context of 376-770, were expressed in COS-7 cells for BS3 cross-linking. Wild 
type remained mostly as monomers; higher complexes were comparatively less (lane 
2). Both helix-disrupting mutants were predominantly tetrameric upon BS3 treatment 
(lanes 4 & 6).  
lysate, 
anti-Flag WB 
             wt      L668G      h
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GIT1 oligomerisation might also affect PIX binding; thus GIT1 (L668G) and GIT1 (1-
646) were analysed for their interaction with 1PIX (Figure 3.10, page 50). Flag-GIT1 
and deletion mutants were expressed in COS-7 cells and endogenous 1PIX associated 
with these Flag-GIT1 immuno-precipitates was determined (panel A). GIT1 (L668G) 
precipitated equivalent amounts of 1PIX as wild type GIT1 despite its lower 
expression level (compare lanes 1 & 2). GIT1 (1-646) precipitated approximately three 
times more 1PIX than wild type GIT1 (lanes 3 & 4). This effect can be attributed to 
GIT1 oligomerisation as both GIT1 (1-646/LZ) and GIT1 (LZ) mutants precipitated 
comparatively less 1PIX than wild type (lanes 5 & 6). Thus GIT1 oligomerisation 
clearly increases PIX binding; both GIT1 (1-646) and GIT1 (L668G) that had enhanced 
oligomerisation also showed an increase in 1PIX binding.  
 
In panel B, GIT1 (376-770) was analysed for its ability to complex with endogenous 
GIT1 and 1PIX proteins. Flag-GIT1 (376-770) was expressed in COS-7 cells, anti-
Flag immuno-precipitate and lysate were resolved in parallel to compare relative 
amount of endogenous proteins co-precipitated in WB analysis. GIT1 (376-770) 
precipitated a substantial amount of endogenous GIT1 as compared to the level in the 
lysate (anti-GIT1 WB), and an equivalent amount of endogenous 1PIX was co-
precipitated (relative to that in lysate). This probably reflects the ability of GIT1 (376-
770) to oligomerise with endogenous GIT1 and precipitate 1PIX. 
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Figure 3.10 (A): GIT1 oligomerisation increased PIX affinity. Flag-GIT1, Flag-
GIT1 (L668G), Flag-GIT1 (1-646), Flag-GIT1 (LZ) and Flag-GIT1 (1-646/LZ) were 
expressed in COS-7 cells. Flag-GIT1 and mutants were immuno-precipitated and 
probed for co-precipitation of endogenous PIX. GIT1 (L668G) that showed enhanced 
oligomerisation precipitated more PIX (lane 2) than wild type GIT1 (lane 1). Similarly, 
GIT1 (1-646) precipitated more PIX (lane 4) than wild type GIT1 (lane 3). The GIT1 
(1-646/LZ) (lane 5) and GIT1 (LZ) mutants (lane 6) had reduced PIX binding.  
 
 
Figure 3.10 (B): GIT1 (376-770) oligomerised with endogenous GIT1 and 1PIX. 
Flag-GIT1 (376-770) was expressed in COS-7 cells and immuno-precipitated. 




























 1        2                            3       4       5       6
  endogenous PIX
  endogenous GIT1
  GIT1 (376-770)





   51
 
IV GIT1-1PIX interaction for recruitment to FCs might be negatively 
regulated by PAK phosphorylation  
 
Unlike the situation with Cdc42- and Rac-type FCs, the GIT1 protein complex was 
present at low levels at Rho-type FCs because of local PAK kinase activity (Zhao et 
al., 2000b, Brown et al., 2002). The role of GIT1-1PIX interaction in their 
recruitment to FCs was analysed using the point mutants in co-transfection with KID to 
suppress PAK activity. In (Figure 3.11, pages 52-53), GFP-GIT1 was detected at Rho-
type FCs stained with paxillin (panels A & B). By contrast, the GIT1 (m4) seldom 
localised at FCs although it retained the paxillin BD (panels C & D). As expected, 
GIT1 (LZ) failed to associate with FCs (panels E & F) reflecting its reduced PIX 
affinity as shown in figure 3.10(A). The weak localisation of the GIT1 (m4) in some 
cells was probably mediated through oligomerisation with endogenous GIT1. For GIT1 
(376-770) which contained both the LZ and paxillin BD, it was localised weakly to 
these cellular sites (data not shown) since it could complexed with endogenous GIT1 
and 1PIX as shown in figure 3.10(B). A similar PKL mutant (GIT2 homologue) was 
localised to FCs (Brown et al., 2002). Thus in addition to GIT1-paxillin  interaction, 
GIT1-1PIX interaction is necessary for FC targeting. Similarly for 1PIX, it was 
localised to FCs (panels G & H) but the GIT1-binding deficient 1PIX mutant was not 
or weakly targeted (panels I & J). 1PIX has a coiled coil domain at its carboxyl 
terminus responsible for its recruitment to membrane ruffles (Koh et al., 2001). This 
1PIX mutant might form a complex with endogenous PIX protein. 
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GFP-GIT1 wild type + GST-KID 
 





GFP-GIT1 (D294K/E295R) + GST-KID 
 





GFP-GIT1 (LZ) + GST-KID 
 






Figure 3.11: GIT1-1PIX interaction and oligomerisation were critical for FC 
targeting. Legend is on next page. 
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GFP-1PIX wild type + GST-KID 
 





GFP-1PIX (I539P/E540G) + GST-KID 
 





Figure 3.11: GIT1-1PIX interaction and oligomerisation were critical for FC 
targeting. GFP-GIT1, GFP-GIT1 (D294K/E295R, m4) or GIT1 (LZ) mutants were 
co-expressed with GST-KID in HeLa cells. The asterisk indicates a transfected cell in 
each panel, bar 10M. Cells were immuno-stained with anti-GFP (for GFP-GIT1 
expressions) and anti-paxillin. Wild type GIT1 was concentrated at paxillin-containing 
FCs (A & B). GFP-GIT1 (D294K/E295R, m4) was weakly localised to these sites (C 
& D). GFP-GIT1 (LZ) was predominantly cytoplasmic and nuclear but was not 
localised to FCs (E & F). Similarly for GFP-1PIX, it was concentrated at FCs (G & 
H). However, the GFP-1PIX (I539P/E540G) lost this FCs localisation (I & J). 
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Endogenous PAK was not detected immunologically at FCs in HeLa cells (data not 
shown). Since PIX recruited PAK to FCs (Manser et al., 1998), it was of interest to see 
if elevated GIT1 and 1PIX protein levels could promote recruitment of endogenous 
PAK to these sites in HeLa cells (Figure 3.12, page 55). In GIT1 and 1PIX co-
transfected cells, 1PIX was localised to the FCs (panel A) and indeed the endogenous 
PAK was detected by the anti-phospho PAK antibody at these sites (panel B).  
 
When KID was expressed in these HeLa cells to inhibit endogenous PAK activity 
(Figure 3.13, page 56), KID was localised to these FCs (panels C & D) revealing the 
presence of endogenous PAK.  Both 1PIX (panel F) and GIT1 (panel G) levels at 
these sites were consistently elevated as compared to control non-transfected cells. The 
vinculin level was unaltered at these FCs with KID expression (panel H). This KID 
effect is specific to PAK inhibition since KID L107F mutant did not stabilise the 
protein complex at FCs (data not shown, also documented by Zhao et al., 2000a). The 
L107F mutation in the context of full- length PAK was associated with kinase 
activation (Lei et al., 2000). 
 
Wild type PAK and catalytic inactive (T422A) mutant were expressed in HeLa cells 
(Figure 3.14, page 57). Wild type PAK was present in the cytoplasm (panels I & J) or 
associated with internal membranes (Dharmawardhane et al., 1997). Consistent with 
the KID effect, the PAK (T422A) mutant was readily detected at FCs (panels K & L) 
probably influenced by the stabilisation of endogenous GIT and PIX proteins at these 
sites.  
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 Flag-GIT1 wild type + Ha-1PIX wild type  










Figure 3.12: Active PAK was present at FCs in GIT1 and 1PIX co-expressed 
HeLa cells.  Flag-GIT1 and Ha-1PIX were co-expressed in HeLa cells, transfected 
cells are indicated with an asterisk, bar 10M. 1PIX was localised to the FCs (A), 
anti-phospho PAK antibody recognised active PAK at these sites (B). Arrowheads 














C : anti-GST                         D : anti-Vinculin                  Merged 
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Figure 3.13: PAK kinase inhibition stabilised PIX and GIT1 at FCs. The KID 
transfected HeLa cells are indicated with asterisk. Clearly, GST-KID itself was 
localised to vinculin-containing FCs (C & D). Endogenous PIX (E & F) and GIT1 (G 
& H) proteins were enriched at these FCs in KID transfected cell (*) than neighbouring 
non-transfected one (#). KID expression did not change the protein level of vinculin at 
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GST-PAK wild type  
 





GST-PAK (T422A)  
 










Figure 3.14: Catalytic inactive PAK stabilised at FCs. HeLa cells was transfected 
with wild type GST-PAK or catalytic inactive GST-PAK (T422A). Transfected 
cells are indicated with an asterisk, bar 10M. Wild type PAK was present mainly in 
the cytoplasm and was weakly associated with the vinculin-containing FCs 
(arrowhead) (I & J). In contrast, PAK (T422A) mutant was readily localised to FCs (K 
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Previously auto-phosphorylation of PAK was proposed to down regulate the PAK-
PIX interaction (Zhao et al., 2000a). Conversely PAK inhibition by KID would 
stabilise this PAK-PIX interaction at FCs (Zhao et al., 2000b, Brown et al., 2002). In 
my analysis, PAK auto-phosphorylation at Ser 198/203 did not disrupt PIX binding 
(data not shown) hence an alternative mechanism by which active PAK destabilises the 
protein complex was sought for. GIT1 and 1PIX are known substrates of PAK 
(Manser et al., 1997); there are two PAK phosphorylation sites within rat GIT1 at 
serine 261 and serine 517 (Zhao Z.S., unpublished data). Serine 261 is present in a ‘8-
residue’ insert in GIT1 (in rat but not the human homologue) and serine 517 and its 
flanking sequences are conserved between GIT1 and GIT2. 1PIX phosphorylation 
sites are mapped to serine 525 and threonine 526 (Koh et al., 2001) but these sites are 
not conserved in Drosophila dPIX. Phosphorylation at these residues did not  affect 
GIT1 binding. The GIT1 serine 517 was substituted with alanine (S517A) in 
recombinant GIT1 (376-770) protein (Figure 3.15, page 60). In panel A, recombinant 
PAK failed to phosphorylate this S517A mutant (lane 2) as compared to wild type. 
PKA control was found to phosphorylate the GIT1 protein equally in both cases (lanes 
3 & 4).  
 
The GIT1 (S517A) mutant appeared to be more stable at FCs (brighter immuno-
staining) than wild type (data not shown). This GIT1 phosphorylation site lies close to 
the leucine zipper domain and might alter the extent of oligomerisation. To test this, 
Flag-GIT1 (376-770) immuno-precipitate was incubated with recombinant PAK to 
phosphorylate serine 517, and followed by BS3 cross-linking (panel B). There was 
equal distribution of GIT1 monomer and cross-linked oligomer (anti-Flag WB). 
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Significantly, only the monomeric and dimeric species were labelled with [33P] 
phosphate. This suggests GIT1 phosphorylation by PAK could cause dissociation of 
the GIT1 oligomer into dimer and monomer or there was selective labelling of the 
smaller species. This GIT1 phosphorylation might represent a potential means to down 
regulate GIT1-1PIX interaction. 
 
HeLa cells have predominantly Rho-type FCs and expression of constitutively active 
Cdc42 (G12V) leads to appearance of Cdc42-type FCs at the cell periphery (Fig. 3.4). 
This re-organisation involved PAK kinase activity as KID blocked this Cdc42 effect 
(Zhao et al., 1998). The physiological relevance of this GIT1 serine 517 
phosphorylation was analysed in HeLa cells (Figure 3.16, page 61). At low expression 
levels, GFP-GIT1 was detected at the nascent Cdc42-type FCs (panels M & N). 
However, GFP-GIT1 (S517A) mutant persisted at Rho-type FCs (arrowheads) and 
blocked the formation of Cdc42-type FCs in majority of transfected cells (panels O & 
P) which was similar to that of KID. Thus GIT1 phosphorylation at serine 517 is 
necessary for its turnover at Rho-type FCs and might be important for FCs dynamics. 
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Figure 3.15: Monomeric and dimeric GIT1 species were phosphorylated at serine 
517 by PAK. (A) Recombinant GIT1 (376-660) and S517A mutant proteins were 
thrombin cleaved to remove GST tag. Both proteins were incubated in GST-PAK or 
PKA kinase reaction, PAK did not phosphorylate S517A mutant (lane 2) while PKA 
phosphorylated both proteins (lanes 3 & 4). (B) Flag-GIT1 (376-770) was expressed in 
COS-7 cells, and immuno-precipitated for in vitro GST-PAK phosphorylation. BS3 
cross-linker was then added to these immuno-precipitates for 30 min and resolved with 
SDS-PAGE gel for WB and autoradiograph. Only GIT1 monomeric and dimeric 
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GFP-GIT1 wild type + Ha-Cdc42 (G12V) 
 





GFP-GIT1 (S517A) + Ha-Cdc42 (G12V) 
 









Figure 3.16: GIT1 serine 517 phosphorylation was implicated in its turnover at 
FCs. HeLa cells were transfected with constitutively active Cdc42 (G12V) and GFP-
GIT1 wild type (M & N) or with Cdc42 (G12V) and GIT1 (S517A) mutant (O & P). 
GIT1 wild type protein was present at the Cdc42-type FCs (asterisk, M & N). 
However, the GIT1 (S517A) mutant and paxillin persisted at Rho-type FCs 
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V GIT1-1PIX interaction translocated the protein complex to the TX-100 
insoluble cellular fraction  
 
When GIT1 and 1PIX were co-expressed in COS-7 cells, little GIT1 or 1PIX 
proteins were present in the clarified supernatant of cell lysate extracted with 1% TX-
100. It was therefore of interest to investigate the effect of the interaction between 
GIT1 and 1PIX, for their partitioning into Triton-X100 soluble (S) and –insoluble 
(IS) fractions. The IS fraction was then extracted with SDS-containing buffer for WB 
analysis (Figure 3.17, page 63). When GIT1 was expressed alone it was predominant 
in the S fraction (lane 1). GIT1 and 1PIX co-expression relocated both proteins to the 
P fraction (lane 4), the remaining 1PIX in the S fraction could be due to higher 
expression level of 1PIX than GIT1. This effect was dependent on their interaction as 
shown by the co-expression of GIT1 and 	PIX (I539P/E540G) mutant which were 
found predominantly in the S fraction (lane 5). Endogenous Rho GDI is a cytoplasmic 























Figure 3.17: GIT1-1PIX interaction translocated both proteins to a TX-100 
insoluble cellular fraction. Flag-GIT1 alone, Flag-GIT1 and Ha-	PIX or Flag-GIT1 
and 	PIX (I539P/E540G) were expressed in COS-7 cells and lysed with 1% TX-100 
containing buffer (refer to scheme). Lysate was passed through a 29-gauge insulin 
syringe 5 times and spun at 14,000 rpm for 10 minutes after which the supernatant (the 
S fraction) was collected. The pellet was washed with 0.5ml buffer for 30 min to 
remove trace amount of the soluble material. The pellet was then re-extracted with 2% 
SDS sample buffer; the solublised material was the P fraction. Equal proportions of the 
S and P fractions were resolved with SDS-PAGE for WB analysis. GIT1 on its own 
was present predominantly in the S fraction (lane 1), GIT1 and 	PIX co-expression 
shifted both to the P fraction (lane 4) but both GIT1 and 	PIX (I539P/E540G) 
remained in the S fraction (lane 5). Endogenous RhoGDI protein was present in the S 
fraction (cell fractionation control). 
anti-Flag
anti-Ha
WB :S       P       S       P        S       P
Flag-GIT1    +                 +                 + 
Ha-1PIX            -                 +                 m
anti-RhoGDI
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In order to assess which domain of GIT1 was responsible for partitioning it to the P 
fraction in the presence of 1PIX, a number of deletion constructs were generated (Fig. 
3.18 & 3.19). In (Figure 3.18, page 65), it can be seen that the GIT1 leucine zipper 
deletion (LZ) mutant was not efficiently partitioned to the P fraction (lane 8) as 
compared to wild type (lane 4), perhaps as a result of its reduced affinity for PIX. The 
proportion of GIT1 (1-646) mutant partitioned to the P fraction (lane 12) was similar to 
wild type. Hence paxillin  binding through the carboxyl terminus was not necessary 
for GIT1 partition. This effect was also independent of 1PIX-PAK interaction as 
illustrated by the 1PIX SH3 mutant (lane 14). 1PIX expressions on their own were 





















Figure 3.18: GIT1 paxillin  BD and 1PIX-PAK interaction were not involved in 
its translocation to the TX-100 insoluble cellular fraction. Flag-GIT1 expression 
alone was present slightly more in S fraction (lane 1), majority of Flag-GIT1 and Ha-
1PIX co-expression were in P fraction (lane 4). Flag-GIT1 (LZ) expression alone 
was in S fraction (lane 5), Flag-GIT1 (LZ) and Ha-1PIX co-expression were 
partially present in P fraction (lane 8) but were not as efficiently as wild type. Flag-
GIT1 (1-646) expression alone was in S fraction (lane 9), Flag-GIT1 (1-646) and Ha-
1PIX co-expression were mostly in P fraction (lane 12). GIT1 (1-646) and Ha-1PIX 
SH3 mutant co-expression were predominantly in P fraction (lane 14). Ha-1PIX or 
Ha-1PIX ‘SH3’ mutant expression alone was in S fraction (lanes 15 & 17).    
S       P        S       P       S       P         S        P      S      P
Flag-GIT1 1-646        +                 +                +                   -                 -
Ha-1PIX                   -                  +             SH3m              +             SH3m





S       P       S       P       S        P       S       P
Flag-GIT1     +                 +             LZ             LZ
Ha-1PIX            -                  +                -    +
 1       2       3       4        5        6       7       8
WB :
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GIT1 amino terminus deletion mutants, i.e. deletion of the Arf GAP domain (117-770) 
or Arf GAP plus ankyrin repeats (254-770) and GIT1 carboxyl terminus half (376-770) 
were analysed (Figure 3.19, page 67). Both the GIT1 (117-770) and (254-770) mutants 
were mostly recovered in the P fraction independently of 1PIX (lanes 6 & 10). This 
suggests a role of the Arf GAP domain in regulating this GIT1 cellular localisation. 
GIT1 (376-770) was completely soluble (S faction) since it lacked the PIX BD (lanes 
13 & 15). These GIT1 deletion mutants and their behaviour with respect to detergent 
solubility are summarised in Fig. 3.19A. A shorter GIT1 (1-504) mutant was insoluble 
in presence of 1PIX (data not shown). Hence it appears GIT1 translocation to the P 
fraction depends on its SHD-I domain that mediates 1PIX interaction, and is probably 
regulated by the amino terminus Arf GAP domain.  
 
                        
 
                                                                              P Fraction         
   --------------------------------------------1-646         + (with PIX) 
   ---------------------------------- 1-504                     + (with PIX) 
            117-770 --------------------------------------------     + 
254-770 ------------------------------------     + 
                        376-770 ---------------------------      - 
 
 
Figure 3.19A: (Data Summary) The schematic diagram represents GIT1 domain 
organisation. These GIT1 deletion mutants are represented by the dotted lines. The 
GIT1 region responsible for P fraction localisation is mapped to the SHD-I domain. 
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Figure 3.19: GIT1 Arf GAP domain regulated its translocation to the TX-100 
insoluble cellular fraction. Flag-GIT1 (117-770) and (254-770) expressions alone 
were mostly distributed in the P fractions. The co-expression with Ha-1PIX 
partitioned these Flag-GIT1 mutants to the P fraction completely. Flag-GIT1 (376-770) 
expression alone, Flag-GIT1 (376-770) and Ha-1PIX co-expression were present in S 
fraction. Flag-GIT1 (376-770) lacked the SHD-1 (PIX binding site). Ha-1PIX 
expression is not shown.                                               
                                                                                                     
 S       P       S       P       S       P       S       P
Flag-GIT1            +                +          117-770      117-770 
Ha-1PIX             -                +                -                  + 
 S      P       S       P        S       P       S       P
Flag-GIT1     254-770      254-770     376-770       376-770 
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Since GIT1 and 1PIX play a key role in PAK localisation, GIT1 and 1PIX co-
expression was further analysed in the presence of PAK (Figure 3.20). PAK when 
co-expressed with either 1PIX (lane 1) or GIT1 (lane 2) were present in the S 
fraction. However, the combined expressions of GIT1 and 1PIX with PAK 
partitioned the majority of GIT1 and PAK to the P fraction (lanes 3 & 4) and this 
effect was independent of PAK activity (lane 7). The GIT1 (m4) and 1PIX 
(I539P/E540G) mutants that fail to bind their respective wild type partner maintained 
PAK in the soluble pool (lanes 5 & 6). 
 
Figure 3.20: GIT1-1PIX interaction translocated PAK to the TX-100 insoluble 
cellular fraction.  PAK was exclusively soluble (S fraction) when co-expressed with 
1PIX (lane 1), or with GIT1 (lane 2), and GIT1-1PIX interaction increased the 
amount of PAK resistant to TX-100 extraction (lanes 3, 4 & 7), independently of 
kinase activity (lane 7). PAK remained in S fraction when co-expressed with GIT1- 
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Nature of the GIT1-1PIX protein complex 
The immuno-precipitation of endogenous GIT1/PIX/PAK proteins from NIH3T3 cell 
lysate has established their existence as a physiological protein complex. GIT1 and 
1PIX were present at peripheral FCs during cell spreading and in Cdc42-expressed 
cells. Significantly, the associated PAK was active at these FCs indicating GIT1 and 
PIX provide spatial regulation of PAK activity. This is consistent with the coupling of 
Rac1-PAK activation in adherent cells but in not suspended cells (del Pozo et al., 
2000). In this case, it appeared that the sequestration of active Rac1 by RhoGDI 
prevented interaction with effectors such as PAK in the cytoplasm. Cell adhesion 
promoted displacement of RhoGDI from Rac1 to allow Rac1-effector interaction at 
membranes/FCs (del Pozo et al., 2002).  
 
In my attempt to understand the role of GIT1-1PIX interaction in FCs recruitment and 
activation of PAK (Chapter 5), GIT1- and 1PIX point mutations defective in mutual 
binding were generated. Previous studies on GIT1, PKL and APP1 involved the use of 
deletion mutants but few detailed analyses of these binding domains are reported.  
 
In the GIT1 SHD-I analysis, substitution of D294/E295 with basic or alanine residues 
abolished 1PIX binding and implicates the first repeat in 1PIX binding. Deletion of 
either repeats (R1 or R2) from the SHD-I also abolished 1PIX binding (data not 
shown). This is likely due to gross conformational change associated with these 
deletion mutants. Besides 1PIX and FAK (Zhao et al., 2000b), Piccolo-a protein 
implicated in the formation of the presynaptic active zone was also associated with the 
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GIT1 SHD-1 region (Kim et al., 2003). In their analysis, four mutations were generated 
in the first repeat and only GIT1 (L288A) lost piccolo binding (refer to Summary of 
GIT1 SHD-I mutations). These mutations had no effect on PIX interaction. That 
multiple proteins binding to the SHD-I is not surprising since this region of yeast 
Spa2p was also implicated in different MEKK interactions to facilitate alternate 
MAPK signalling pathways (Sheu et al., 1998).  
 
By my criteria the 1PIX (I539P/E540G) cannot interact with GIT1 which is similar to 
an analysis using the neighbouring residue PIX (V538A) (Feng et al., 2002). 
 
Summary of GIT1 SHD-I mutations 
SHD-I mutations 1PIX binding SHD-I mutations Piccolo binding 
R283/L284F (m1)  +   I285A   + 
E286S/E287R (m2)  +   L288A   - 
D291K/V292L (m3)  +/-   
D294K/E295R (m4)  - 
E295A    +/- 
D294A/E295A  +/-   R298A   + 
R298L/R299E (m5)  +/-   R299A   + 
D355K/I356L (m6)  +/-   
S358K/E359R (m7)  + 
R362L/R363E (m8)  + 
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Intrinsic repression of GIT1 oligomerisation 
 
The leucine zipper domain drives the formation of GIT1 oligomers, Kim et al. (2003) 
reported that GIT1 homo-dimerised or hetero-dimerised with GIT2 as shown by 
sucrose-gradient centrifugation. Data obtained in my studies suggest that GIT1 exists 
as a larger complex and that its carboxyl terminus  helix might exert a constraint over 
oligomerisation. This is illustrated with the GIT1 (L668G)- and helix deletion mutants 
that were highly cross-linked as tetramers. Since GIT1 interaction with 1PIX was 
much more robust in its oligomeric form, this could be used as a read-out for the state 
of GIT1 oligomerisation. Clearly 1PIX interaction was enhanced with the GIT1 
carboxyl terminus deletion mutant, GIT1 (1-646). Over-expression of GIT1 (1-646) in 
HeLa cells produced membrane extensions and FCs, dependent on PIX-binding and 
Rac1 (data not shown). For PKL (chicken GIT2 homologue), over-expression of a 
carboxyl deletion mutant (which included removal of this helix) caused Rac1 
dependent lamellipodia formation (West et al., 2001). Thus, this PKL mutant 
phenotype might be attributed to up-regulation of oligomerisation and increased PIX 
binding (and Rac1 activation). Similarly in APP1 studies, a 347-740 fragment (p95-C) 
caused Rac dependent membrane protrusions (di Cesare et al., 2000). This phenotype 
could be through the sequestering of endogenous GIT and PIX proteins by this p95-C.  
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GIT1-1PIX interaction for recruitment to FCs  
In HeLa cells, the FCs are predominantly of the Rho-type and unaffected by dominant 
inhibitory Rac1 or Cdc42. Using point mutants of GIT1 and 1PIX that were defective 
for mutual binding, I have been able to probe the role of their interaction in FCs 
targeting. Such GIT1 and 1PIX mutants failed to efficiently localise to FCs. Although 
a minority of cells showed proper localisation for GIT1 (m4), this could be accounted 
for by its oligomerisation with endogenous wild type GIT1 or GIT2 proteins. This is 
strengthened with the finding that the leucine zipper domain was absolutely crucial for 
localisation to FCs. Thus both GIT1 and 1PIX provide structural elements to 
associate with FCs and thereby recruiting PAK. Perhaps this is facilitated by GIT1-
paxillin  interaction (West et al., 2001, Brown et al., 2002) and the up-regulation of 
this interaction by 1PIX (Zhao et al., 2000b). The detailed analysis on the regulation 
of GIT1-paxillin interaction and its role for FCs targeting will be described in 
Chapter 4. 
 
PAK phosphorylation could regulate GIT1 oligomerisation 
GIT1 phosphorylation sites were originally mapped using recombinant PAK (Zhao, 
Z.S., unpublished data). Subsequently, I have shown that the site of PAK 
phosphorylation in the carboxyl terminal half of GIT1 is uniquely serine 517. 
Additional residues around this site in GIT2 are conserved where phosphorylation is 
likely to play an analogous role.  In cross-linking experiments, phosphorylated GIT1 
migrated in SDS polyacrylamide gels as monomer and dimer. Those that behaved as 
larger GIT1 oligomers were not phosphorylated (or that these oligomers cannot be 
phosphorylated). This suggests PAK phosphorylation of GIT1 at serine 517 
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downregulates oligomerisation. Whether this is the mechanism to down-regulate GIT1-
PIX interaction remains to be tested. Nevertheless, the GIT1 (S517A) mutant persisted 
at the Rho-type FCs and blocked the formation of Cdc42-type FCs. Phospho antibody 
will reveal GIT1 phosphorylation by PAK kinase activity in vivo for regulating protein  
dynamics at FCs. 
 
GIT1 and 1PIX translocation to the TX-100 insoluble fraction might correspond 
to cytoskeletal fraction or lipid compartment 
In the GIT1 and 1PIX co-expression experiment, the 1PIX (I539P/E540G) mutant 
has demonstrated that GIT1-1PIX interaction partitioned both proteins to a TX-100 
insoluble fraction in COS-7 cells. The GIT1 domain required for this behaviour was 
mapped to the SHD-I; thus 1PIX binding would likely alter the SHD-I conformation 
and promote translocation of the protein complex. Moreover PAK was translocated 
together with GIT1 and 1PIX to this insoluble fraction, an effect that did not occur 
with PAK and 1PIX co-expression. This TX-100 insoluble fraction might 
correspond to cytoskeletal fraction or membrane lipids; the latter has emerged to 
modulate integrin function at FCs (Pande, 2000). 
    
Curiously APP1 (chicken GIT1 homologue) deletion mutant was localised to large 
aberrant Rab11-positive vesicles (Matafora et al., 2001, Albertinazzi et al., 2003); the 
lack of Arf GAP and the presence of SHD-I in APP1 were necessary for the 
accumulation of APP1, PIX and PAK at these membrane compartments. The 
association of GIT1 and 1PIX at this Rab11-positive membrane remain to be tested in 
my system. 
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Chapter 4 Regulation of GIT1-paxillin  interaction 
 
I GIT1 ankyrin repeats and oligomerisation in regulating paxillin  binding  
 
Paxillin is a FCs adaptor protein (Figure 1.1) and its interaction with GIT1 is 
reported to tether GIT1 protein partners at these sites (Brown et al., 2002). In GIT1, the 
paxillin  BD was mapped to residue 646-770 (Zhao et al., 2000b), which shares 77% 
sequence identity with GIT2. Full length GIT1 was a weaker paxillin binder while its 
carboxyl terminus half (376-770) had enhanced binding. GIT1-paxillin  interaction 
was positively regulated by 1PIX (Zhao et al., 2000b). In PKL (chicken GIT2 
homologue), this binding site was mapped to a paxillin binding sequence (PBS2) at 
residues 643-679 (West et al., 2001) which is conserved in GIT1 and GIT2.  
 
To investigate how 1PIX might regulate the GIT1-paxillin  interaction, the ability of 
GIT1 to bind Ha-1PIX and Ha-paxillin was compared (Figure 4.1, page 75). Ha-
1PIX with Ha-paxillin Flag-GIT1were expressed separately in COS-7 cells to 
avoid protein insolubility due to GIT1-1PIX interaction. The relative amount of Ha-
1PIX and Ha-paxillin in Flag-GIT1 immuno-precipitate was determined by anti-Ha 
WB.Flag-GIT1 did not precipitate Ha-paxillin laneexcept in the presence of 
Ha-1PIX (lane 4) confirming our previous report (Zhao et al., 2000b). GIT1 
precipitated significantly more 1PIX than paxillin  considering their relative ratios 
in the lysate (lane 2)therefore the GIT1-paxillin interaction is significantly weaker 
than that to 1PIX. When compared to Flag-GIT1 (376-770) positive control (lane 5), 
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it co-precipitated much more paxillin  than GIT1 plus 1PIX. The relative binding for 







Figure 4.1: GIT1 precipitated more 1PIX than paxillin . Flag-GIT1 and Flag-
GIT1 (376-770) were expressed separately from Ha-1PIX and Ha-paxillin  in COS-
7 cells. The expression levels of Ha-paxillin  in the lysate (lanes 1 & 2) were 
approximately five times higherthan Ha-1PIX. These lysates were mixed prior to 
anti-Flag immuno-precipitation. Flag-GIT1 alone did not precipitate paxillin lane 3), 
however some Ha-paxillin was recovered in the presence of Ha-1PIX(lane 4). The 
positive control Flag-GIT1 (376-770) precipitated significantly more Ha-paxillin 
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One model for the underlying regulation of 1PIX would be GIT1 intra-molecular 
constraint that represses paxillin binding to GIT1 (relative to GIT1 [376-770]). The 
GIT1 amino-terminus deletion mutants were analysed for paxillin  interaction 
(Figure 4.2, page 77). Here, Flag-GIT1, Flag-GIT1 (118-770), GIT1 (255-770) and 
GIT1 (376-770) were co-expressed with Ha-paxillin  in COS-7 cells and tested for 
binding to each other. GIT1 lacking the first 117 residues had little paxillin  
precipitated (lane 2), but further deletion of the ankyrin repeats yielded a protein that 
precipitated comparable amounts of paxillin  (lane 3) as GIT1 (376-770) (lane 4). 
Thus the GIT1 ankyrin repeats appears to prevent paxillin  binding, suggesting a 
possible interaction of this domain with the carboxyl terminus paxillin  BD.  
 
Ankyrin repeats are involved in both inter- and intra-molecular protein-protein 
interactions but this module does not bind selectively to any single class of protein 
target (Sedgwick and Smerdon, 1999). The proposed constraint by the GIT1 ankyrin 
repeats was analysed for physical interaction between the ankyrin repeats and the 
carboxyl terminus sequences. This GIT1 ankyrin repeats (GST-ANK), residue 118-254 
was co-expressed with Flag-GIT1 (376-770) or Flag-GIT1 (254-770) in COS-7 
(Figure 4.3, page 78). Flag-GIT1 (376-770) and Flag-GIT1 (255-770) specifically 
precipitated GST-ANK but not the GST tag. The interaction was weak but would be 
consistent with a low affinity intra-molecular interaction. 








Figure 4.2: Intrinsic repression by the ankyrin repeats over GIT1-paxillin  
interaction. Flag-GIT1, Flag-GIT1 (118-770), Flag-GIT1 (254-770) or Flag-GIT1 
(376-770) mutants were co-expressed with Ha-paxillin  in COS-7 cells. As before, 
Flag-GIT1 did not precipitate Ha-paxillin  (lane 1), deletion of 1st amino terminus 
117 residues had little or no effect (lane 2). However, Flag-GIT1 (254-770) 
precipitated comparable amount of Ha-paxillin lane 3) asFlag-GIT1 (376-770) (lane 
4). The expression levels of Ha-paxillin  were equal in these lysates. The ankyrin 
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Figure 4.3: Weak intra-molecular interaction between GIT1 ankyrin repeats and 
carboxyl terminus sequences. Flag-GIT1 (376-770) or Flag-GIT1 (254-770) was co-
expressed with GST control or GST-ankyrin repeats (GST-ANK) in COS-7 cells. Both 
Flag-GIT1 (376-770) and GIT1 (254-770) precipitated GST-ANK (lanes 2 and 3) but 
not the GST control (lane 1). This interaction was weak as the GST-ANK signal was 
detected after 2 hours of chemiluminesence exposure. 
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A shorter version of GIT2 (GIT2-short) was also reported to bind paxillin  (Mazaki et 
al., 2001). GIT2-short is essentially the amino terminal half of GIT2 that terminates 
after the leucine zipper domain; GIT2-short exhibits weak binding to paxillin  but this 
is a controversial finding (Premont et al., 2000).  
 
To assess the potential for additional paxillin binding sites, GIT1 deletions covering 
the various domains were generated (Figure 4.4, page 80). The LD4 is the binding 
motif in paxillin and binds very efficiently to GIT1 as compared to full-length 
paxillin  (data not shown). GIT1 (1-646) lacking the paxillin  BD (Zhao et al., 
2000b) lost LD4 binding (lane 1). Similarly the helix breaking GIT1 (L668G) mutant 
failed to bind LD4 binding (lane 2), besides promoting oligomerisation as shown in 
figure 3.9. The paxillin LD motif is predicted to form an alpha helix with the leucine 
residue providing a hydrophobic interface for protein binding (Turner, 2000). Hence in 
GIT1, the putative helix within this paxillin  BD might be involved. The amino 
terminus deletions including the Arf GAP (lane 3), the ankyrin repeats (lane 4) and the 
two repeats in SHD-I (lanes 5 & 6) were unaffected in LD4 binding. Notably, the LZ 
deletion weakened LD4 binding (lane 7). The LZ is unlikely to constitute a paxillin 
binding site but might indirectly modulate binding affinity as for 1PIX as shown in 
figure 3.10. Therefore, there is no evidence by this experimental criterion that suggests 
a second binding site for paxillin in GIT1. 
 
   
 
 







GIT1 deletion mutants    
1 1-646 (paxillin BD) 
2  L668G 
3  118-770 (Arf GAP)  
4  121-325(ANK) 
5  282-325(R1, SHDI)  
6  328-375 R2, SHDI)                    
7  424-480(LZ) 
 
Figure 4.4: GIT1 extreme carboxyl terminus (residue 646-770) contained the only 
paxillin BD. GIT1 wild type (wt) and mutant constructs (labelled 1-7) were 
expressed in vitro as [35S]-Met labelled proteins, and passed through a sepharose 
column with immobilised GST-paxillin  LD4. The GIT1 (1-646) and GIT1 (L668G) 
exhibited no binding (1 & 2), GIT1 (leucine zipper) had reduced binding (7) to LD4. 
All other GIT1 deletion mutants (3-6) bound LD4 as efficiently as wild type.   
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           GST                       GST-LD4 pull-down 
          control
[35S]- 
Input
100             200           300            400            500            600            700
Arf          Ankyrin       SHD-I  Leucine                 Paxillin 
GAP        repeats                       zipper                    binding
GIT1 schematic diagram
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A number of mutations of the putative helix (present within the paxillin  BD) were 
generated in the context of GIT1 (376-770) and tested for GST-LD4 binding (Figure 
4.5, page 82). The helix deletion (h) mutant (corresponding to PBS2 of PKL) behaved 
identical to the L668G mutant suggesting this putative helix has a direct role in paxillin 
 binding. Other substitutions (1-8) were not predicted to disrupt the helical structure 
and indeed none were affected in paxillin LD4 binding. These GIT1 (376-770) mutants 
were also analysed with full-length paxillin  and the results were identical (data not 
shown).  
 
This putative helical coiled coil structure is conserved between GIT1 and GIT2; GIT1 
L668 corresponds to GIT2 L657. The GIT2 L657 and L658 were substituted with 
glycine to see if the same effects would operate in GIT2 (Figure 4.6, page 83). 
Unexpectedly, this GIT2 (L657G) mutant had slightly enhanced LD4 binding (lane 10) 
than wild type GIT2 (lane 6), the GIT2 (L658G) was normal (lane 11). Thus these 
helix-disrupting mutations produced opposite outcomes in GIT1 and GIT2 despite their 
high sequence identity (77%) in this region. It might be that the paxillin  binding 
functions of GIT1 and GIT2 isoforms require a larger domain that encompassing this 
helix. A number of GIT1 and GIT2 deletion mutants were generated to test the notion 
that additional sequences at the carboxyl terminus are required for paxillin binding. 
GIT1 lacking the last 11 residues retained LD4 binding (376-759, lane 3), but a 63-
residue deletion (376-707, lane 4) failed to bind. In the case of GIT2, a 30-residue 
deletion (368-729, lane 7) was sufficient to abolish LD4 binding, indicating that 
residues 729-759 participate in binding. This is in contrast to PKL (chicken GIT2 
homologue) studies where the paxillin  binding site was mapped to different region 
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(PBS2). It is likely that some of these GIT1, GIT2 and PKL deletion mutants adopt a 
conformation that prevents paxillin  binding and the residues do not directly contact 









Figure 4.5: GIT1 helix deletion lost paxillin binding. GIT1 paxillin  BD contains 
a putative helix; residues within this helix were mutated in the GIT1 (376-770) context 
(GIT1 helix mutations). These GIT1 cDNAs were expressed in vitro as [35S]-Met 
labelled proteins and passed through a sepharose column containing GST-LD4.  GIT1 
L668G (*) and deletion mutant (h, 663-674) failed to bind to the LD4 column, while 
other mutations (1-8) had no effect. 
                              1  2  *     3        5    6        8 
                              A A G     A         A  A        A 
660  Q V T K N I Q E L L R A A Q E F K H  677 
                                            E              R




                         wt      *      h       1        2        3         4        5        6        7        8
GST-LD4 
pull down
* helix breaking mutation






Figure 4.6: The paxillin  binding function of GIT1 and GIT2 was conformation 
dependent. Deletions were made to the GIT1 and GIT2 cDNAs using internal 
restriction sites. The cDNAs were expressed in vitro as [35S]-Met labelled proteins 
and passed through a sepharose column containing GST-LD4. The 63-residue carboxyl 
terminal deletion from GIT1 failed to bind LD4 (lane 4) while all carboxyl terminal 
deletions including a 30-residue deletion from GIT2 prevented binding (lanes 7-9). In 
contrast to GIT1 (L668G) (lane 2), the equivalent mutation in GIT2 (L657G) bound 
LD4 normally (lane 10). Therefore the paxillin binding function of GIT1 and GIT2 
might not depend on the helix per se.   










6 GIT2 (368-759) 
7 GIT2 (368-729) 
8 GIT2 (368-711)
9 GIT2 (368-623)
10 GIT2 (368-759, L657G)
11 GIT2 (368-759, L658G)
GIT1 & GIT2 carboxyl terminus deletion mutants
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GIT1-paxillin  interaction might be modulated by oligomerisation as suggested in 
figure 4.4. Since the GIT1 (L668G) mutation failed to bind paxillin , a GIT1 hybrid 
oligomer consisting of both wild type and L668G mutant would provide useful data on 
the GIT1-paxillin  interaction (Figure 4.7, page 85). Flag-GIT1 (376-770) or Flag-
GIT1 (376-770, L668G) was co-expressed with Ha-GIT1 (376-770) and Ha-paxillin  
in COS-7 cells (panel A). Flag-GIT1 (376-770) protein co-precipitated equal amounts 
of Ha-GIT1 (376-770) and Ha-paxillin  (lane 1). However, while Flag-GIT1 (376-
770, L668G) co-precipitated significant amount of Ha-GIT1 (376-770), but little Ha-
paxillin was present(lane 2). Thus Ha-GIT1 (376-770) had lost its ability to bind Ha-
paxillin  due to the presence of the mutant (dominant negative effect). 
 
The ability of GIT1 oligomers to bind the paxillin  LD4 motif was analysed (panel B). 
Flag-GIT1 (376-770) was co-expressed with GST-LD4 or GST control in COS-7 cells, 
BS3 was added to the lysate for Flag-GIT1 (376-770) cross-linking prior to GST 
purification. GST-LD4 pull down contained both GIT1 tetramers and monomers (lane 
2). The control GST pull down did not contain Flag-GIT1 (376-770) (lane 1) or Flag-
GIT1 (376-770, L668G) (lane 3), indicating specific interaction of LD4 with the cross-
linked GIT1. Thus, paxillin  LD4 could interact with the oligomeric GIT1 species. 
Since the hybrid GIT1 (376-770) failed to bind paxillin it appears that paxillin BD 
is only functional in an oligomeric state.  




Figure 4.7: GIT1 oligomeric species co-precipitated by paxillin LD4. (A) 
Different tagged GIT1 (376-770) and GIT1 (376-770, L668G) were co-expressed with 
Ha-paxillin  in COS-7 cells. In anti-Flag immuno-precipitates, heteromeric GIT1 
(376-770) oligomers failed to precipitate paxillin (lane 2. (B) Flag-GIT1 (376-770) 
or Flag-GIT1 (376-770, L668G) was co-expressed with GST or GST-LD4 in COS-7 
cells. Lysates were cross-linked with BS3 before passing through GST-sepharose. 
Oligomerised form of GIT1 (376-770) was bound to the LD4 as shown in lane 2.   
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Besides the GIT1-paxillin  interaction,  and PAK were reported to interact 
directly with paxillin  (Hashimoto et al., 2001). This would provide a direct means of 
recruiting PAK to paxillin containing FCs. Therefore I tested paxillin  for such direct 
binding to 1PIX andPAK (Figure 4.8, page 87). In panel A, Flag-GIT1 co-
precipitated both Ha-1PIX and Ha-paxillin  (lane 1) while Flag-GIT1 (L668G) 
mutant precipitated Ha-1PIX but not Ha-paxillin  (lane 2) indicating GIT1 was the 
principal paxillin  binder. Flag-1PIX and GST-PAK failed to precipitate 
appreciable levels of paxillin  (lanes 3 & 4). However the faint bands seen on this blot 
might represent paxillin  (in lanes 2 & 3). In a direct test of 1PIX and LD4 binding 
(panel B),1PIX failed to bind GST-LD4 above the non-specific level seen with GST 
alone. Thus PAK interaction with paxillin was detected at levels close to the 
background. 
 





Figure 4.8: Paxillin associated with the GIT1/PIX/PAK protein complex 
primarily through direct binding to GIT1. Flag-GIT1, GIT1 (L668G) mutant, Ha-
1PIX or Flag-1PIX, Ha-paxillin  and GST-PAK were expressed in vitro as [35S]-
Met labelled proteins. Combinations of these were mixed for anti-Flag immuno-
precipitation and GST pull down as depicted in (A). Flag-GIT1 precipitated both Ha-
1PIX and Ha-paxillin  (lane 1). Flag-GIT1 (L668G) precipitate contained Ha-1PIX 
but no Ha-paxillin  (lane 2), Flag-1PIX did not precipitate Ha-paxillin  (lane 3). 
GST-PAK pull-down did not contain Ha-paxillinlane 4)rule out any residual 
Ha-paxillinbound to the Flag-1PIX immuno-precipitate laneGIT1 and1PIX 
were passed through GST and GST-LD4 columns (B). 1PIX had no specific binding 
to LD4. 
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II  GIT1 Arf GAP domain and paxillin  translocation to FCs 
 
The importance of paxillin  interaction for recruiting PKL protein partners to Rho-
type FCs has been demonstrated using the PKL (PBS2) mutant; expression of this 
mutant abrogated PKL and PAK localisation to FCs (Brown et al., 2002). Since 
targeting of GIT1 and associating proteins to FCs was negatively regulated by PAK 
activity as shown in figure 3.13, it was of interest to look at the paxillin binding 
deficient GIT1 mutants when co-expressed with KID or in the S517A background 
(Figure 4.9, page 89). A small number of these GFP-GIT1 mutants transfected HeLa 
cells exhibited localisation of the proteins to the peripheral Rac-type FCs but not at the 
interior Rho-type ones (data not shown). With KID co-expression, these GIT1 mutants 
appeared at the Rho-type FCs (panels A & B, E & F). And the GIT1 (S517A/L668G) 
was more clearly seen at these sites (panels C & D). This data is at odds with the 
notion that the GIT1-paxillin  interaction alone contributed to FC targeting of the 
GIT1 and its protein partners.  
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GFP-GIT1 (L668G) + GST-KID 
 
A : anti-GFP                         B : anti-Paxillin                    Merged 
 
 
GFP-GIT1 (S517A/L668G)  
 
C : anti-GFP                         D : anti-Paxillin                   Merged 
 
 
GFP-GIT1 ( Paxillin BD) + GST-KID 
 





Figure 4.9: GIT1 paxillin defective binding mutants associated with FCs. GIT1 
(L668G) or GIT1 ( Paxillin BD) was co-expressed with KID to suppress PAK 
activity. The GIT1 (S517A/L668G) double mutant cannot be phosphorylated by PAK. 
GIT1 (L668G) and GIT1 ( Paxillin BD) mutants were associated with the Rho-type 
FCs in the presence of KID (A & B, E & F), or when it lacked the PAK 
phosphorylation site serine 517 (C & D).  
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Deletion of the Arf GAP domain from APP1 (GIT1 homologue) induced re-
localisation to Rab11 positive vesicles (Matafora et al., 2001). The effect of the Arf 
GAP domain on GIT1 localisation was analysed in HeLa cells (Figure 4.10, pages 91-
92): the zinc co-ordinating cysteine residues were substituted with glycine (C11/14G) 
to disrupt the Arf GAP protein folding. Expression of GFP-GIT1 (C11/14G) led to cell 
collapse, for reasons that were not apparent. In these transfected cells, endogenous PIX 
was present in cytoplasmic aggregates (panel A). This GIT1 mutant was also co-
expressed with Cdc42 (G12V); interestingly paxillin was present in the cytoplasmic 
pool (panel C) and not at peripheral FCs as in wild type GIT1 (panel B).  
 
The GIT1 (G178P/Q179R) mutant (affecting the ankyrin repeats) also appeared to 
induce cell collapse (panels D & F). Endogenous PIX (panel E) and paxillin (panel G) 
in these transfected cells were present in dotty structures near the peri-nuclear region. 
These GIT1 mutants might interfere with membrane trafficking events necessary for 
paxillin translocation to FCs (Norman et al., 1998, Mazaki et al., 2001). Interestingly 
paxillin was redistributed to Rab11-positive vesicles in cells expressing a Arf GAP 
mutant of APP1 (Matafora et al., 2001, Albertinazzi et al., 2003).   
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                          Flag-GIT1 (C11/14G) 
                          A : anti-PIX 
 
 
                                                  Flag-GIT1 wild type + Ha-Cdc42 (G12V)       
                                                  B : anti-Paxillin      
 
                          Flag-GIT1 (C11/14G) + Ha-Cdc42 (G12V)    





Figure 4.10: GIT1 Arf GAP and anykrin repeats might regulate paxillin 
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                                          GFP-GIT1 (G178P/Q179R)  
 
                                          D : anti-GFP                    E : anti-PIX 
  
                                          
 






Figure 4.10: GIT1 Arf GAP and anykrin repeats might regulate paxillin 
localisation to FCs in HeLa cells. GFP-GIT1 (C11/14G) alone or with Cdc42 (G12V) 
or GIT1 (G178P/Q179R) were expressed in HeLa cells. Both GIT1 mutants caused cell 
collapse (panels A, D, F) and endogenous PIX- (arrowheads, panels A & E) and 
paxillin (arrowhead, panel G) were present as cytoplasmic aggregates in these 
transfected cells. In GIT1 (C11/14G) expressing cells, paxillin was concentrated near 
the nucleus (arrowheads, panel C) but not at Cdc42-type FCs as compared to cells in 
control panel B.  


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III Novel GIT1-PKA interaction and its regulation on paxillin   binding 
 
A kinase was observed to co-purify with GIT1 from COS-7 lysate and phosphorylated 
GIT1 (Figure 4.11, page 94). Flag-GIT1 and Flag-GIT1 (376-770) were expressed in 
COS-7 cells, immuno-precipitated and incubated with ATP or with recombinant PAK 
as control (panel A). Both Flag-GIT1 and Flag-GIT1 (376-770) were phosphorylated 
by this co-purified kinase (lanes 1 & 3) and the latter was phosphorylated to the same 
extent as by recombinant PAK (compare lanes 3 & 4). Flag-GIT1 (376-770) might 
precipitated more kinase than Flag-GIT1 thus accounting for the difference in 
phosphorylation level. To map the phosphorylation site, shorter GST-GIT1 constructs 
were co-expressed with Flag-GIT1 (375-646) and immuno-precipitated (panel B). 
These smaller GST-GIT1 constructs were associated with Flag-GIT1 (375-646) 
through oligomerisation, with the smallest GIT1 (375-563) fragment also 
phosphorylated by the kinase (lane 4).   
 
GIT1 was phosphorylated by PKA as shown in figure 3.15. Inspection of the primary 
sequence of GIT1 revealed serine 419 (having the consensus of Rx1-2S/T) as a potential 
PKA site that is also present in GIT2. When this GIT1 serine 419 was substituted with 
alanine, PKA failed to phosphorylate the protein (Figure 4.12, page 95) demonstrating 
that this represents the exclusive PKA site in the GIT1 carboxyl terminus.  
 




Figure 4.11: GIT1 co-precipitated a kinase from COS-7 lysate. (A) Flag-GIT1 wild 
type and Flag-GIT1 (376-770) were expressed in COS-7 cells and immuno-
precipitated. GIT1 immuno-precipitates were incubated with [33P]-ATP (with or 
without GST-PAK). Both GIT1 and GIT1 (376-770) were phosphorylated in PAK 
absence (lanes 1 and 3). (B) Flag-GIT1 (376-646) was co-expressed with shorter GST-
GIT1 constructs to map the phosphorylation site. To differentiate this from the PAK 
site, these shorter GST-GIT1 constructs were S517A mutated. Flag-GIT1 (376-646) 
co-precipitated these smaller GST-GIT1 constructs and incubated with [33P]-ATP. 
The co-precipitated kinase phosphorylated the smallest GIT1 (376-563) fragment (lane 
4). 
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Figure 4.12: A putative PKA phosphorylation site at serine 419 in GIT1. (A) A 
conserved PKA consensus site lies at serine 419 in GIT1 and serine 415 in GIT2; this 
site was substituted with alanine (S419A) in GIT1 for analysis. Flag-GIT1 wild type 
and Flag-GIT1 (S419A) mutant were expressed in COS-7 cells and then immuno-
precipitated. The GIT1 immuno-precipitates were incubated with PKA; PKA did not 
phosphorylate GIT1 (S419A). 





PKA  consensus site 
RARS  S419 in GIT1 
RQKS  S415 in GIT2 
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Since PKA phosphorylated GIT1 at serine 419 in vitro, it is possible that the co-
purified kinase with GIT1 from COS-7 might be PKA (Figure 4.13). The PKA 
holoenzyme consists of both regulatory domain (RI or RII type) and the catalytic 
domain (cd). Therefore, GST-PKA cd and Ha-RII were co-expressed with Flag-GIT1 
(376-770) and anti-Flag immuno-precipitated (panel A). GIT1 (376-770) had 
reasonable PKA cd binding. On the contrary, the presence of RII decreased this binding 






Figure 4.13: Binding of GIT1 to PKA. (A) Flag-GIT1 (376-770), GST-PKA cd and 
Ha-RII were expressed in COS-7 cells and anti-Flag immuno-precipitated. Flag-GIT1 
(376-770) immuno-precipitate contained reasonable amount of GST-PKA but 




+        +       +        + 
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Flag-GIT1 deletion mutants were co-expressed with Ha-PKA cd to map the binding 
region (panel B). Flag-GIT1, Flag-GIT1 (1-504) and Flag-GIT1 (376-770) mutants all 
bound Ha-PKA cd: GIT1 (1-504) was the most efficient possibly due to its 
oligomerised state. The region of GIT1 found to bind PKA construct was identical to 
that associated with the kinase from COS-7 lysate in figure 4.11, suggesting the latter 
was in fact PKA. The minimal PKA binding site in GIT1 is mapped to residue 376-504 







Figure 4.13: GIT1 (376-504) associated with PKA cd. (B) Flag-GIT1, GIT1 (1-504) 
or GIT1 (376-770) was co-expressed with GST-PKA cd in COS-7 cells and anti-Flag 
immuno-precipitated. All three GIT1 immuno-precipitates contained PKA and GIT1 
(1-504) had the highest amount (lane 2). Note that GIT1 (1-504) expression was lower 
and not detected at this exposure in the total lysate (lane 6). 
 
Flag-GIT1
GST-PKA cd       +       +       +       +
1-5
04
   anti-Flag IP                     Lysate
     antiGIT1
antiPKA
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Since the PKA phosphorylation site at serine 419 is close to the leucine zipper domain 
(424-460) it might regulate GIT1 oligomerisation. To test this, the GIT1-paxillin  
interaction was used as a read-out in this experiment. Flag-GIT1 (376-770), Flag-GIT1 
(376-770, S419A) or Flag-GIT1 (376-770, L668G) mutants were co-expressed with 
Ha-paxillin  in COS-7 cells (Figure 4.14, page 99). These lysates were incubated 
with ATP to allow PKA associated with Flag-GIT1 (376-770) to phosphorylate serine 
419 (lanes 1-6), and additional PKA cd was added to the lysate (lanes 4-6). These Flag-
GIT1 (376-770) and mutants were then immuno-precipitated and assessed for Ha-
paxillin  co-precipitation. The amount of paxillin  precipitated by GIT1 (376-770) 
was substantially less than the GIT1 (S419A) mutant suggesting that serine 419 
phosphorylation down-regulates GIT1 and paxillin  interaction, possibly through 


























Figure 4.14: PKA phosphorylation of GIT1 reduced GIT1-paxillin  interaction. 
Flag-GIT1 (376-770), GIT1 (S419A) or GIT1 (L668G) mutant was co-expressed with 
Ha-paxillin  in COS-7 cells. Lysate was divided into 2 portions and either incubated 
with 10M ATP (lanes 1-3) or 10M ATP and 50U PKA (lanes 4-6) at 30oC for 30min 
in the presence of 20M -glycerophosphate (general phosphatase-inhibitor) prior to 
immuno-precipitation. GIT1 (S419A) mutant co-precipitated more paxillin than 
GIT1 (376-770) in both instancesGIT1 (L668G) mutant is the negative control.
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GIT1-paxillin  interaction 
The PKL (chicken GIT2 homologue) and paxillin  interaction has been suggested to 
be the molecular link to recruit PKL protein partners to FCs (Brown et al., 2002). 
Overall sequence identity between PKL and GIT1 is 65% and both have functional 
paxillin  binding activity. Therefore, it was of interest to look into greater detail of the 
molecular regulation of GIT1-paxillin  interaction. I have shown the up-regulation of 
GIT1 and paxillin  interaction by 1PIX did not achieve that observed with carboxyl 
terminal construct such as GIT1 (376-770). The original aim in the GIT1 SHD-I 
mutational analysis in figure 3.5 was to generate GIT1 mutant that mimicked the ‘PIX-
bound’ conformation through substitution with opposite charged amino acid. 
Unfortunately none of these GIT1 mutations show increased paxillin  binding (data 
not shown). However a GIT1 mutant harbouring a deletion of the ankyrin repeats, 
GIT1 (ANK), exhibited paxillin binding comparable to GIT1 (376-770). This 
supports the observation that a weak intra-molecular interaction between the anykrin 
repeats domain and the carboxyl terminus sequences normally blocks paxillin binding.  
 
The GIT1 paxillin  BD is mapped to a conserved carboxyl terminal domain as in PKL 
(West et al., 2001). This binding domain might involve a larger folded structure than 
the paxillin binding sequences (PBS) apparently mapped in various other paxillin 
binders (Turner et al., 2001, Schaller, 2001). In support of this are the point mutational 
analysis of the helix (within the PBS) and carboxyl deletion analysis (see summary on 
next page). The GIT1 (L668G)- and the helix deletion mutants perturbed paxillin 
   101
 
interaction but mutations of  other residues in this helix (M) had no effect indicating 
that they do not directly contact the paxillin  LD4 motif.  Furthermore the equivalent 
GIT2 (L657G) mutation had normal paxillin binding, indicating that the paxillin 
binding function of GIT1 and GIT2 does not depend on this helix per se.Instead it 
might be dependent on a protein conformation that was probably stabilised by this 
helix in GIT1 (but not in GIT2). This is supported by the findings that the deletion 
mutant (707) from its carboxyl terminus (while retaining the PBS) was sufficient to 
abolish paxillin binding; this deletion was likely to alter local protein conformation. 
 






Schematic summary: GIT1 mutational analysis for paxillin  binding.  
 
1PIX and PAK did not interact with paxillin  in my analysis indicating GIT1 is the 
direct and only link with paxillin . Under conditions where PAK was inhibited, GIT1 
(L668G) recruitment to FCs apparently occurred independently of paxillin 
bindingBearing in mind that this GIT1 (L668G) also promoted oligomerisation, I 
have also ruled out GIT1 (L668G) recruitment through endogenous GIT1-paxillin  
interaction since the hybrid GIT1 oligomer no longer bind paxillin  in figure 4.7. 
Furthermore, GIT1 (ANK) with increased paxillin  binding did not associate with 
G
M
                                                                                  
707
Paxillin  binding 
+ 
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FCs as well (data not shown). The GIT1 (C11/14G) mutation with a disrupted Arf 
GAP domain caused cell collapse and re-distribution of endogenous PIX to 
cytoplasmic aggregates. Interestingly, paxillin was not at FCs in these Cdc42 co-
transfected cells. This suggests a possible role of GIT1 in regulating paxillin  intra-
cellular distribution although direct interaction might not be necessary since paxillin  
(LD4) mutant was localised normally at FCs (Brown et al., 2002). Mutation in GIT1 
ankyrin repeats (G178P/Q179R) also induced similar effect in HeLa cells. The identity 
of these GIT1 aggregates remains to be determined. As inferred from the PAP 
structural studies, the ankyrin repeats have a structural role in stabilising the Arf GAP 
domain (Mandiyan et al., 1999). As was first described for APP1, these GIT1 ArfGAP 
mutants might implicate GIT1 in membrane trafficking pathways (de Curtis, 2001). 
 
Possible role of GIT1-paxillin  interaction  
GIT1 targeting to FCs requires the leucine zipper oligomerisation domain, and paxillin 
 is shown to bind oligomerised GIT1. It is possible that paxillin binding maintains 
GIT1 in an oligomerised state and localisation at FCs. Conversely, uncoupling of GIT1 
and paxillin  may increase the dynamic turnover of GIT1 at FCs. This idea is 
consistent with the faster turnover of the GIT1 (L668G) mutant by PAK kinase at FCs. 
The effect of this GIT1 (L668G) mutant is tied in with its ability to oligomerise and 
activate PAK kinase (Chapter 5). At present, the effect on oligomerisation and paxillin 
 binding function in this GIT1 paxillin  binding region cannot be separated as in 
L668G mutation.  
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The GIT1-paxillin interaction leads to FC disassembly (Zhao et al., 2000b). This 
effect is similarly seen with FAK; one phenotype of FAK-/- cells is stable FCs (Ilic et 
al., 1995). Paxillin binding by GIT1 is important for the effect since GIT1 (L668G) did 
not cause FCs disruption (data not shown). Depletion of GIT1 and GIT2 by siRNA will 
provide an alternate means to address the role of these proteins in FCs dynamics. 
 
Novel GIT1-PKA interaction 
GIT1 was purified with a protein kinase and a novel interaction between GIT1 (376-
504) and PKA was observed. Unexpectedly this GIT1 and PKA interaction was not 
mediated by the regulatory subunit RII, as found in almost all PKA interactions 
(reviewed by Diviani and Scott, 2001, Michel and Scott, 2002). This suggests that 
PKA regulation of GIT1 (or vice versa) could be independent of cAMP signalling 
acting on the PKA/RII holoenzyme, however the RII might compete with GIT1. PKA 
phosphorylation of GIT1 at serine 419 appeared to reduce paxillin  binding to GIT1, 
whether this PKA effect is a direct consequence on GIT1 oligomerisation remains to be 
tested. Similar PAK phosphorylation and cross-linking of GIT1 experiment will be 
needed to address this issue. Both PAK and PKA phosphorylate GIT1 at sites near the 
leucine zipper domain (435-476), and are therefore in a position to influence 
oligomerisation while events in the carboxyl terminus may augment its function. 
Antibodies that recognise these phospho-sites will be useful for analysis of GIT1 
function in the cellular context. 
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Chapter 5 PAK kinase activation can be induced by GIT1 and 
1PIX 
 
I Co-operative effect of GIT1 and 1PIX in PAK kinase activation 
PIX is characterised by two isoforms PIX and PIX, with the latter exhibiting many 
alternate spliced versions (Koh et al., 2001); with 	PIX being the predominant form 
in tissue-cultured cells. It was therefore of interest to investigate how PIX isoforms 
affect the phosphorylation status of PAK (Figure 5.1, page 105). PAK on it own 
was weakly auto-phosphorylated at Ser144 but not Ser198/203 (lane 1). This PAK 
auto-phosphorylation was suppressed by the presence of - and 	PIX (lanes 2, 4 & 6). 
Under these conditions 2PIX was not co-purified with PAK (lane 3); which was 
probably related to the lack of coiled coil dimerisation domain (Koh et al., 2001). 
Unexpectedly, GIT1 addition to the cell system greatly enhanced PAK auto-
phosphorylations at Ser144 and Ser198/203 (lane 7). PAK also underwent mobility 
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  COS-7 expressions 
      
              Ha-GIT1 wt                                                      +                 + 
 
              GST-PAK wt           +        +       +       +       +        +       + 
 
              Flag-1PIX m                                                              +       + 
 
              Flag-PIX wt                        2     1 
                                                 1       2       3       4        5        6       7 
                                                    
     
                                                    
Figure 5.1: PIX isoforms suppressed PAK auto-phosphorylation. PIX isoforms or 
1PIX ‘GIT1 defective binding’ mutant (I539P/E540G) was co-expressed with PAK 
in COS-7 cells. PAK was purified and incubated with kinase buffer containing 10M 
ATP. Note that 1PIX but not 2 PIX were co-purified with PAK. PAK auto-
phosphorylation profile was analysed with site-and phosphorylation-specific antibodies 
(abbreviated as p Ser144, p Ser198/203). These PIX isoforms did not promote but in 
fact suppressed PAK auto-phosphorylation at Ser144 (lanes 2, 4 & 6). In triple 
transfection (lane 7) the presence of GIT1 greatly enhanced PAK auto-
phosphorylations at Ser144 and Ser198/203. 1PIX (I539P/E540G) was used to avoid 
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To follow-up on GIT1’s positive effect on PAK auto-phosphorylation, GIT1 mutants 
characterised in previous chapters were co-expressed with PAK to access their effect 
on PAK kinase activity (Figure 5.2, page 107). Purifed PAK was incubated with 
peptide substrate and ATP, the peptide substrate consisted of two tandem repeats of 
GDKRDSMVGAP; the aspartic acid (D) at the –1 position prevented phosphorylation 
by any contaminating basic directed kinases co-purified with PAK (Tuazon et al., 
1997). Consistent with previous report, PAK expressed in COS-7 cells had negligible 
kinase activity as shown in lane 1 (Manser et al., 1997). GIT1 expression clearly 
increased PAK kinase activity toward the substrate (lane 2), the GIT1 (1-646) 
mutants lacking the paxillin  BD (lane 3) and those with the PIX deficient binding 
mutations (lanes 4 & 5) were equally effective. These results suggest that paxillin  
and 1PIX binding functions are not necessary for GIT1-induced PAK activation. 
The kinase inactivePAK (T422A) mutant had no activity (lane 6) and indicates that 
substrate phosphorylation was specific toPAK activation. The modest degree of 
substrate phosphorylation and no mobility shift of PAK indicate that PAK was not 





















Figure 5.2: GIT1 induced PAK activation. Flag-GIT1, Flag-GIT1 (1-646) or with 
(D294K/E295R or D294A/E295A) mutants was co-expressed with PAK or PAK 
(T422A) in COS-7 cells. PAKs was purified from lysates and incubated with kinase 
buffer containing 10M [33P]-ATP and 10g substrate at 30oC for 30min. GIT1 and 
mutants activated PAK, and PAK (T422A) remained inactive. 
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The GIT1 (PIX defective binding) mutants suggested that GIT1-PIX interaction is not 
necessary for activating PAK. The role of protein interactions within the 
GIT1/1PIX/PAK complex was directly addressed; two 1PIX mutants were 
employed I539P/E540G (GIT1 defective binding) and W43P/W44G (PAK defective 
binding). In triple transfection (Figure 5.3, page 109), PAK was clearly auto-
phosphorylated at Ser144 and Ser198/203 in the presence of 1PIX (I539P/E540G) and 
GIT1 (lane 2), confirming the previous observation that GIT1- 1PIX interaction is not 
necessary. This positive effect is attributed to the presence of GIT1 since PAK was not 
auto-phosphorylated when co-expressed with only 1PIX mutant alone (lane 1). 
However the 1PIX (W43P/W44G) mutant was ineffective (lane 3) suggesting that 
1PIX-PAK interaction is critical for PAK auto-phosphorylation in the presence of 
GIT1. To address this issue, both mutations were introduced into one 1PIX construct 
(denoted by asterisk) and this particular 1PIX mutant was able to restore PAK auto-
phosphorylation (lane 4). Thus 1PIX-PAK interaction is not necessary but GIT1-
1PIX interaction somehow suppresses GIT1 effect on PAK auto-phosphorylation. 
This suggests that in vivo regulation of the GIT1 and 1PIX interaction can control the 





Figure 5.3: GIT1-1PIX interaction was not necessary for GIT1-induced PAK 
activation. GIT1, 1PIX (I539P/E540G) or 1PIX (W43P/W44G) or 1PIX mutant 
that incorporated both sets of mutations (denoted by asterisk) and PAK were co-
expressed in COS-7 cells. Cells were lysed with 2% SDS since GIT1-1PIX interaction 
rendered these proteins insoluble to TX-100 extraction. Thus PAK was not purified 
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II GIT1 Arf GAP domain and PAK kinase activation 
Flag-GIT1 and various deletion mutants were co-expressed with Ha-1PIX 
(I539P/E540G) to assess their role in PAK auto-phosphorylation and kinase activation 
(Figure 5.4, page 112). The three PAK auto-phosphorylation sites previously 
identified in our laboratory (Manser et al., 1997) were analysed with antibodies raised 
against phospho-peptides corresponding to these sites. Two of these sites are present in 
the regulatory region (Ser 144 and Ser 198/203) while Thr 422 is the sole site in the 
kinase domain and is critical for kinase activity towards substrates (Zenke et al., 1999, 
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Figure 5.4(A): The GIT1 schematic diagram is for reference to the GIT1 deletion 
mutants.   
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GIT1 (WT & C1) expressions induced PAK auto-phosphorylation at Ser144 and 
Ser198/203 (lanes 1 & 2), while 1PIX (I539P/E540G) expression had no effect (lane 
3). Notably this GIT1 and 1PIX mutant combination induced robust PAK auto-
phosphorylations and mobility shift with the latter correlated to Ser198/203 
phosphorylation (lanes 4, 5, 6 & 9). The GIT1 mutant (C5) was the most potent 
activator as assessed by most complete PAK mobility shift and intensity of Thr422 
auto-phosphorylation (lane 9). The GIT1 ‘leucine zipper’ deletion mutant (C2) was 
expected to remain monomeric but was reasonably active in terms of its effect on PAK 
(lane 6). It appeared that phosphorylation at Ser144 could occur in the absence of 
Ser198/203 modification. This is in agreement with the proposal that modification of 
the kinase inhibitor domain (KID) by Ser 144 phosphorylation occurs before subsequent 
auto-phosphorylation events in - and PAK (Chong et al., 2001). Surprisingly 
constructs encoding GIT1 amino terminus deletions (C3 & C4) failed to activate PAK 
(lanes 7 & 8); the weak auto-phosphorylation at Ser144 was probably due to the in vitro 
ATP incubation. The first 116-residue deletion in C3 removed the Arf GAP domain. 
GIT1 is reported to exhibit Arf GAP activity towards Arf6 (Vitale et al., 2000) which 
implicates Arf6 signalling in GIT1-mediated PAK activation. The amount of 1PIX 
(I539P/E540G) co-purified with PAK did not vary accordingly to the PAK activation 











Figure 5.4: Co-operative effect of GIT1 Arf GAP domain and 1PIX in PAK 
activation. GIT1 or deletion mutants, 1PIX m and PAK were co-expressed in COS-
7. PAKs were purified and incubated with kinase buffer containing 10M ATP. 
PAK activity was analysed with site-and phosphorylation-specific antibodies and the 
mobility shift corresponded to auto-phosphorylation events. GIT1 on its own induced 
PAK auto-phosphorylation (lane 1 & 2), but 1PIX m had no effect (lane 3). Both 
GIT1 and 	PIX m co-operatively induced PAK auto-phosphorylation (lanes 4, 5 & 
9); the GIT1 (1-504) mutant was most effective (lane 9) and GIT1 (LZ) was affected 
moderately (lane 6). Both amino terminus deletion GIT1 mutants lost their activity 
(lanes 7 and 8). The amount of 1PIX co-purified with PAK is shown. 1PIX 
(I539P/E540G) is abbreviated as 1PIX m.  
PAK
p Ser 198/203 
p Thr 422
p Ser 144





WT    C1             WT     C1    C2     C3    C4     C5 
                   +       +        +       +       +       +       + 






The specificity of these antibodies used to probe PAK auto-phosphorylations, and the 
role of auto-phosphorylation for kinase activation was analysed with alanine-
substituted mutants (Figure 5.5, page 114). Auto-phosphorylation of PAK Thr422 
within the kinase activation loop is important for activity toward substrate (Zenke et 
al., 1999, Chong et al., 2001), and the S421D/T422E mutant (acidic residues 
mimicking phosphorylation) was constitutively active (Manser et al., 1997). This 
activation loop phosphorylation is important for activation in many other kinases. 
 
The PAK (T422A) mutant failed to phosphorylate the other two sites in the regulatory 
domain (lane 6) consistent with its inability to phosphorylate substrate as seen in figure 
5.2. The K298A mutant could not co-ordinate ATP binding (Lei et al., 2000) and was 
therefore inactive (lane 7). It is clear from the data that the S144/149A mutant could be 
phosphorylated normally on Ser198/203 but not Thr422 (lane 4). This indicated Ser144 
phosphorylation is not required to drive Ser198/203 phosphorylation. By contrast the 
S198/203A mutant behaved as wild type in terms of auto-phosphorylation at Ser144 
and Thr422 (lane 5) suggesting that Ser198/203 auto-phosphorylation does not play a 
direct role in regulating PAK activity. The extent of Thr422 phosphorylation was 
much lower than phosphorylations at the other two sites since these anti-phospho 
antibodies appeared to be similar in their sensitivity towards active recombinant PAK 







Figure 5.5: Phosphorylation at threonine 422 mirrors serine 144 auto-
phosphorylation of PAK. PAK auto-phosphorylation site mutants were analysed 
for their role in GIT1-induced kinase activation. PAK (S198/203A) mutant had 
comparable phosphorylation at Ser 144 and Thr 422 as compared to wild type (lane 5). 
PAK (S144/149A) mutant activity was greatly compromised (lane 4), both PAK 
(T422A) and (K298A) mutants were inactive (lanes 6 & 7). The PAK auto-
phosphorylation profile was analysed as in the lysate.  
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To assess the potential role of Arf6 in GIT1-induced PAK activation, a dominant 
inhibitory version of Arf6 (T27N) was generated (Figure 5.6, page 116). This Arf6 
mutant appeared to partially block auto-phosphorylation induced by GIT1 (1-504) 
expression (lane 3) and with the combined expressions of GIT1 (1-504) and 1PIX 
(I539P/E540G) (lane 5). On the other hand, the constitutively active Arf6 (Q67L) 
mutant failed to synergies with GIT1 induced PAK activation but blocked GIT1 
effect (data not shown). This suggests that the effects seen might arise from direct 
competition between active Arf6 and other protein factor for binding to the Arf GAP 
domain. Indeed endogenous GIT1 was purified from rat brain lysate with Arf1 and 
Arf6 columns; with the Arf6 (Q67L) mutant being the most efficient (panel B). The 
minimal PIX binding site of PAK (PID100) was included as a control to compare 
relative binding of GIT1 to PAK (through PIX) and to Arfs; GIT1 binding to the 
constitutively active Arf6 was comparable.  
 
Two mutations C11/14G and R39K were generated to address the role of GIT1 Arf 
GAP domain for PAK activation (Figure 5.7, page 117). Disruption of the zinc finger 
in C11/14G mutant would cause localised protein misfolding while the R39K mutant 
was anticipated to abolish Arf GAP activity (Mandiyan et al., 1999). The GIT1 (R39K) 
mutant was almost as effective as wild type in promoting PAK auto-phosphorylations 
except for weaker phospho Thr 422 signal (lane 3).  The GIT1 (C11/14G) mutant 
abolished its effect (lane 4). Thus the ability of GIT1 to drive PAK auto-
phosphorylation depends on the structural integrity of the Arf GAP domain but not 
GAP activity per se.  
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Figure 5.6:GIT1-induced PAK activation was partially blocked by dominant 
negative Arf6 mutant. 
The dominant negative Arf6 (T27N) mutant was included 
in this experiment. Arf6 (T27N) partially blocked PAK auto-phosphorylation at Ser 
144 and Ser 198/203 induced by GIT1 (1-504) (lane 3) and by GIT1 (1-504) and 
1PIXm combination (lane 5). (B) Rat brain lysate was passed through these affinity 
columns, and the affinity-purified fraction was probed for the presence of GIT1. 
Constitutively active Arf6 (Q67L) column bound the most GIT1 among the Arfs. 
PID100 is the minimal PIX-binding site derived from PAK (Manser et al., 1998), 
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Figure 5.7: The zinc finger structure within GIT1 Arf GAP domain was critical 
for PAK activation. Two mutations were generated in the GIT1 Arf GAP domain, 
GIT1 (R39K) and (C11/14G). GST-PAK auto-phosphorylation profile with these 
GIT1 mutants were analysed; GIT1 (R39K) was as effective (lane 3) but (C11/14G) 
mutant abolished its activity completely (lane 4).  
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III The novel PAK activation mechanism was conserved and occurred 
independently of Cdc42 and Rac1 binding 
 
The PAK extreme amino terminus contains the binding site for the second SH3 
domain of Nck (Bokoch et al., 1996). In (Figure 5.8, page 119), the PAK deletion 
mutant (22) lacking the Nck-binding site suggesting that Nck-PAK interaction was 
not required for activation (lane 5) by GIT1. The Cdc42-mediated activation of this 
PAK (22) was normal indicating that the deletion did not perturb the kinase 
integrity (lane 6). PAK was included to assess if the mechanism of activation is 
conserved among PAK isoforms; PAK behaved identical to PAK with respect to 
mobility shift.  
 
Although 1PIX was a weak activator of Rac1 (Manser et al, 1998), its presence 
seemed to inhibit PAK auto-phosphorylation (Fig. 5.1). It is likely that the GIT1 and 
1PIX co-operative role in PAK activation would involve small GTPases Cdc42 or 
Rac1 (Manser et al., 1995). This issue was addressed with the PAK (S76P) mutant 
and by co-expression of dominant negative mutants (T17N) of Cdc42 and Rac1 
(Figure 5.9, page 120). Wild type PAK was activated robustly by consitutively active 
Cdc42 (G12V) (lane 2). The PAK (S76P) was not activated by Cdc42 (G12V) as due 
to no p21 binding (Zhao et al., 1998) (lane 4). Nevertheless this PAK (S76P) was 
activated robustly by GIT1 and 1PIX m (lane 6). Furthermore the PAK activation 
was not be blocked by dominant negative Cdc42 and Rac1 mutants (lanes 9 & 10). 
These data suggest that the activation mechanism neither involve Cdc42 or Rac1 nor 











Figure 5.8:The GIT1-induced activating mechanism was conserved among PAK 
and PAK isoforms. PAK and PAK isoforms were analysed for kinase activation 
by GIT1 and 1PIX (I539P/E540G), they were similarly activated as indicated by the 
mobility shift (lanes 2 & 8). The activation mechanism did not involve the amino 
terminus ‘Nck binding’ residues of PAK (lane 5).  
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Figure 5.9: GIT1-induced PAK activation mechanism was Cdc42 or Rac1 
independent. PAK (S76P, lost p21 binding) mutant, dominant negative Cdc42 and 
Rac1 (T17N) mutants were included to analyse the role of Cdc42/Rac1 in PAK 
activation. Wild type PAK was activated by constitutively active Cdc42 (G12V) (lane 
2) and PAK (S76P) mutant was not (or weakly) activated (lane 4). Nevertheless 
PAK (S76P) was activated by GIT1 and 1PIX m (lane 6). Cdc42- and Rac1 (T17N) 
mutants were not able to abrogate PAK activation by GIT1 and 1PIX m (lanes 9 & 
10). 
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GIT1 as a mediator of PAK activation 
Until now, there was no report that GIT1 activate PAK although Bagrodia et al., 
(1999) mentioned in their discussion that GIT1 (CAT1) and GIT2 (CAT2) did not 
affect PAK3 (PAK) activity. My findings pointed to a number of experimental factors 
that compound detection of GIT1 activation of and PAK. PAK activation was 
more robust in the presence of the non-GIT binding 1PIX mutant. GIT1 (1-504) most 
effectively promoted PAK activation while deletion of the leucine zipper domain 
(424-480) reduced its effect. These observations again highlighted the importance of 
GIT1 oligomerisation for kinase activation and might involve additional protein-
protein interactions other than PIX. Surprisingly the Arf GAP domain of GIT1 played a 
key role in activation of PAK although there was no requirement of its GAP function. 
An effector role of the Arf GAP domain in yeast proteins has been suggested (Zhang et 
al., 1998). In addition the GIT1 (C11/14G) mutation in the Arf GAP domain also 
perturbed GIT1 intracellular localisation to vesicle-like compartment. Thus GIT1 
induced PAK kinase activation might involve spatial regulation where the GIT1 Arf 
GAP regulates membrane trafficking of an addition PAK activator (other than Rho 
GTPases). 
 
Since GIT1 interacted with Arf6 and the latter functions at plasma membrane 
(Cavenagh et al., 1996); it is more physiologically relevant than other GIT1-Arf 
interactions. GIT1 could be considered as an Arf6 effector signalling to PAK 
activation however data using both inhibitory- and active Arf6 mutants did not support 
this. Since the dominant active Arf6 mutant lacks GTPase activity and is 
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predominantly GTP bound, it might compete for binding to GIT1’s Arf GAP domain 
and occlude binding of factor necessary for PAK activation. Arf6 may not function as a 
‘binary switch’ as suggested for Ras and Rho p21s but its GTPase activity is 
nevertheless crucial for its signalling (Di Cesare et al., 2000). The recent 
characterisation of the ‘fast-cycling’ Arf6 (T157A) mutant that loads GTP at a faster 
rate and retains its GTPase activity (Santy, 2002) will probably determine if Arf6 is 
involved in PAK activation.  
 
Previous studies on PAK activation in vivo have focused on PIX as it has been shown 
that 1PIX promoted GTP loading and activation of Rac1 (Manser et al., 1998). Since 
Cdc42 G12V/Y40C (lacking an ability to bind and activate PAK directly) was 
synergistic with 1PIX in PAK activation, a model was proposed whereby 1PIX 
recruited PAK to Cdc42 induced FCs for activation by Rac1.GTP (exchange activity 
dependent manner).  
 
The presence of 1PIX was found to be both positively and negatively modulating the 
ability of GIT1 to activate PAK. The most surprising finding however is that direct 
interaction between GIT1 and 1PIX was not required to drive PAK activation. 
However 1PIX can recruit a negative regulator phosphatase POPX which binds PIX 
directly (Koh et al., 2002), and translocation to the Triton X-100 insoluble 
compartment could place PAK in the vicinity of other negative regulators. These 
events in the cellular context would likely to be determined by the local 
microenvironment, such as within the FCs where PIX and GIT1 colocalised. The 
function of PIX could therefore involve both inhibitory and stimulatory effect on 
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PAK activity and complicates any structure-function analysis. Nevertheless the 
removal of the coiled coil dimerisation domain of 1PIX abolished its ability to 
promote the GIT1 effect on PAK (data not shown). This 1PIX dimerisation is 
necessary for its membrane ruffling activity but not Rac1 exchange activity per se (Koh 
et al., 2001). Thus under over expression conditions the non-GIT1 binding mutant 
(I539P/E540G) was effective in facilitating PAK activation by GIT1 although it 
prevented PAK from associating with FCs (data not shown).  
 
Three lines of evidence indicated that GIT1's effect on PAK was independent of the 
binding of GTPases such as Cdc42 or Rac1. Firstly PAK activation could not be 
driven by PIX alone (i.e. Rac1 activator). Secondly dominant inhibitory Cdc42 or Rac1 
(T17N) mutants failed to block the GIT1 effect. Thirdly and most telling, the PAK 
(S76P) mutant which cannot be activated by these small GTPases, was activated by 
this combination of GIT1 and 1PIX. The binding of Cdc42 to intact PAK is of 
relatively low affinity (Kd 0.6M) (Buchwald et al., 2001) and therefore additional 
‘priming’ steps might facilitate PAK activation. 
 
This novel GIT1 activation mechanism was tested on two PAK isoforms (i.e. rat PAK1 
and PAK3), and did not involve the amino terminus residue involved in Nck binding 
(Bokoch et al., 1996). Because PAK could be activated by sphingosine and 
phosphatidic acid in in vitro conditions (Bokoch et al., 1998, Chong et al., 2001, Roig 
et al., 2001), these are considered as candidate intermediaries for the GIT1/PIX effect. 
This was however PI3-K independent since wortmannin treatment had no effect (data 
not shown).  
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Chapter 6 Conclusions 
 
I A model for the role of GIT1 in PAK signalling (Figure 6.1) 
 
In this thesis, I have shown the existence of an in vivo protein complex consisting of 
GIT1, 1PIX and PAK and their presence at the FCs under specific physiological 
conditions. In the structural and functional analysis of GIT1, GIT1 function(s) in the 
cellular context seemed to be strongly dependent on its oligomerisation status and my 
findings indicated this in turn was auto-inhibited by the ‘paxillin binding’ carboxyl 
terminus domain. This auto-inhibited GIT1 might either exist as monomeric or dimeric 
form; the high affinity PIX binding might relieve this GIT1 auto-inhibition. That the 
GIT1 and 1PIX interaction for FC localisation was dependent on GIT1 leucine zipper 
domain suggested that paxillin binding does not disrupt GIT1 oligomerisation. At 
present it is not clear how these observations are linked to the fact that these proteins 
were enriched at Cdc42-type FCs but less so in Rho-dependent structures. Certainly, 
PAK required recruitment by GIT1/PIX to FCs (Manser et al., 1998) where its kinase 
was activated. Active PAK phosphorylated GIT1 at serine 517 and possibly  weakened 
the stability of the protein complex at FCs (Zhao et al., 2000b). This might represent a 
negative feedback mechanism to limit GIT1 signalling at the FCs.  
 
Because it is shown here that PAK activation can be driven by GIT1/PIX in a 
ArfGAP domain dependent and p21-independent manner, it is important to establish 
physiological conditions under which this occurs. I was unable to show the GAP 
activity of GIT1 towards Arf1 and Arf6 in vitro. Alternatively GIT1 might be acting 
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through its Arf GAP domain to integrate Arf6 mediated signalling pathways, however 
dominant inhibitory Arf6 failed to completely block this GIT1/PIX effect. The ability 
to remove wildtype GIT1/2 from cells by siRNA will allow us to better address the role 
of GIT1 Arf GAP domain and oligomerisation in PAK FC recruitment and kinase 
activation. 
 
Candidate regulators of GIT1 oligomerisation include PAK and PKA kinases. It is 
possible that PKA down regulation of GIT1 oligomerisation feeds back to inhibit PAK 
since PKA and PAK antagonism is evident in anchorage-dependent MAPK stimulation 
(Howe and Juliano, 2000). Other potential regulators include tyrosine kinases 
(Bagrodia et al., 1999, Zhao et al., 2000b), and SH2 containing proteins that are 
subsequently recruited to GIT1. Further hetero-dimerisation of GIT1 and GIT2 could 
impart additional complexity to the physiological regulation of GIT.  
 
Contradictory to reports by Turner & co-workers, GIT1-paxillin  interaction was 
evidently not required for its localisation to FCs under PAK kinase suppression 
conditions. The other possible functions attributed to this interaction include 
disassembly of FCs (Zhao et al., 2000b) and stabilisation of GIT1 oligomerisation 
state. Novel GIT1 protein interaction for example piccolo (Kim et al., 2003) would 



















Figure 6.1: Regulation(s) of PAK FC localisation and kinase activation by GIT1 
and 1PIX. Firstly, GIT1-1PIX interaction allows for targeting to FCs (yellow box), 
under the regulation of GIT1 oligomerisation and possibly its Arf GAP domain. 1PIX 
will recruit PAK subsequently (Manser et al., 1998). Secondly, GIT1 primes PAK 
activation via its Arf GAP domain. GIT1 mutated in the Arf GAP domain is seen in 
aberrant vesicles and lost its PAK activating activity. Therefore the Arf GAP is 
proposed to regulate the membrane trafficking of a PAK activator ‘X’. 1PIX works 
co-operatively with GIT1 in PAK activation but on its own has no effect. This 
activation mechanism does not involve Cdc42/Rac1 and is likely independent of 
1PIX exchange activity. Instead, 1PIX coiled coil domain mediating dimerisation is 
crucial (Koh et al., 2001). Last of all, GIT1- 1PIX interaction is not necessary for 
PAK activation as this may subject PAK to negative regulator like POP X (Koh et 
al., 2002). 
Relieve GIT1 inhibition, 
oligomerisation &  





FC translocation,  




Negative regulation by PAK & PKA 
phosphorylation of GIT1 
Active PAK dissolves actin 
stress fibres & FCs 
Formation of Cdc42 & Rac1  
dependent actin structure ? 
Neurite outgrowth ? 







II  Biological implications for PAK signalling 
Since GIT1 provided localisation and activation cues for PAK, GIT1 therefore acted 
upstream of PAK and integrated diverse signalling inputs to PAK. Examples of such 
signalling inputs are PKA and Arf and represent signalling ‘cross-talk’ with Rho 
pathway. GIT1 and homologues were present in distinct sub-cellular compartments 
(FC, endosomal vesicles etc) and likely to target the GIT/PIX/PAK protein complex to 
these sites. For example active PAK led to a loss of actin stress fibres (Manser et al., 
1997) possibly via down-regulation of myosin light chain kinase (Sanders et al., 1999). 
It is attractive to consider that GIT1 played an analogous role on actin stress fibres to 
allow local activation of PAK at these sites. There is a region in GIT1 that clearly 
associated with actin stress fibres (data not shown), but I had been unable to find 
conditions in which the full-length GIT1 associates with these structures.  
 
The recent described biological activities of GIT1 (or GIT2) would imply PAK 
involvement as well. APP1 and Arf6 were necessary for Rac1B-induced neurite 
outgrowth in retinal neuronal cells (Albertinazzi et al., 2003), this process was 
dependent on the ArfGAP domain of APP1 and therefore might involve PAK 
signalling. The established notion of PIX’s GEF and Rac1 activities for PAK activation 
were apparently not necessary in this novel GIT1 induced PAK activation and the 
precise function of PIX in this aspect remained unclear. Nevertheless, this GIT1 study 
underlined its importance in PAK activation in a p21-independent manner and 
implicated PAK activity in Rac/ Cdc42 dependent structure formation for neurite 
outgrowth. It brought into question the validity of previous reports using the 
Cdc42/Rac1 effector loop mutants (cf Y40C) to rule out PAK involvement in actin 
organisation (Lamarche et al., 1995, Westwick et al., 1997).  
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